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Abstract 
Diabetes mellitus (DM) is a metabolic disorder in glucose homeostasis affecting 
over 150 million people worldwide. Over 90% of the cases are classified as type 2 
DM, which is caused by partial insulin deficiency and insulin resistance. Many 
traditional Chinese herbs and formulae have been used for the treatment of diabetes 
for a long time, but most of their pharmacological effects have not been scientifically 
studied. 
Fourteen herbs were selected from several traditional Chinese herbal formulae used 
for diabetes treatment. In addition, previous in vitro studies indicated the potent anti-
diabetic effect of Cortex Moutan, Rhizoma Smilacis Chinensis and Rhizoma 
Alismatis in vitro. Further fractionation has been processed to isolate the active 
compound(s) in Cortex Moutan. The potential anti-diabetic effects in all the above 
herbs and compounds were investigated using systematic approaches including 
various in vitro and in vivo models. 
Four in vitro screening systems were employed for studying the effect of 
traditional Chinese herbs: (1) Gluconeogenesis in H4IIE hepatoma cells; (2) Glucose 
absorption in brush border membrane vesicles (BBMV); and (3) Glucose uptake in 
3T3-L1 adipocytes and (4) Glucose uptake in Hs68 skin fibroblasts. Neonatal STZ-
diabetic Wistar rat model was used as in vivo model to confirm the results from in 
vitro studies. 
From the results, Cortex Phellodendri, Radix Ophiopogonis and Rhizoma 
Coptidis showed the most significant anti-diabetic effects among the 4 in vitro assays. 
However, none of the three herbs show significant hypoglycaemic and anti-
hyperglycaemic effect in diabetic rat model. Cortex Moutan, Rhizoma Smilacis 
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Chinensis and Rhizoma Alismatis mixture in ratio 1:1:1 also did not exert any 
synergistic anti-hyperglycaemic effect. From the result of BBMV assay, it revealed 
that both hexane and dichloromethane extract of Cortex Moutan had very potent 
inhibitory effect on intestinal glucose absorption. Upon further investigations, five 
pure compounds (CM-Dl to 5) were purified from dichloromethane extract (CM-D). 
Using mass spectrometry and nuclear magnetic resonance techniques, the structures 
were elucidated, and they were identified as 2,5-dihydroxy-4-methylacetophenone 
(CM-D3), 2,5-dihydroxy-4-methoxyacetophenone (CM-D4) and 3-hydroxy-4-
methoxyacetophenone (CM-D5). CM-Dl was identified as paeonol by another 
student previously. These four compounds, together with acetovanillone (which is 
also a compound found in Cortex Moutan), they showed significant suppression of 
glucose absorption in BBMV model. Sulfonation of paeonol (sodium paeonol 
sulfonate) showed no suppression of glucose absorption in BBMV model. CM-Dl 
and CM-D3 (both had very potent effects in BBMV assay) and acetovanillone were 
studied in vivo. Both 200 and 400 mg/kg of paeonol showed significant anti-
hyperglycaemic effect in STZ-diabetic rat model, but the activity was not as strong 
as metformin (200 mg/kg); on the other hand, synthesized CM-D3 and 
acetovanillone did not show any effect on improving oral glucose tolerance. 
Further studies should be done on studying the other mode of action in type 2 
DM, exploring the structure-activity relationship of the compound purified from CM-
D in BBMV model and investigating synergistic effect on the herbs in order to make 
a new herbal formula on treating type 2 DM. 
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2，5—二烴基一4一甲氧基苯乙酮（C M — D 4 )及3 —氫基一4一甲氧基 
苯乙酮，（ C M - D 5 ) � C M- D 1 則已被另一位硏究員確定爲丹皮酚 °以 
上四個化合物再加上另一個同樣是牡丹皮活性成分的夾竹桃麻素均有顯著抑制 
小腸吸收葡萄糖吸收。磺化丹皮酷鈉則沒有抑制小腸吸收葡萄糖吸收之作用° 
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Chapter 1 Introduction 
1.1 Epidemiology of Diabetes Mellitus 
Diabetes Mellitus (DM) or diabetes is a chronic and progressive metabolic disorder 
of glucose homeostasis which affects more than 150 million people in all age groups 
(International Diabetes Federation, 2000). The global figure of people with diabetes is 
rising, with at least 171 million people worldwide have DM in 2000，and the number is 
likely to be doubled or more by 2030 (World Health Organization, 2004a). 
Prevalence of DM in developed and developing countries was 6.2% and 3.5% 
respectively in year 2000 (King et al., 1998). DM caused 1.7% (around 988 thousands) 
of death worldwide in 2004, with mortality higher than stomach cancer, and it is ranked 
the second cancer killer (World Health Organization, 2004b). The majority of diabetic 
patients have type 2 DM; only 5 to 10% are suffering from type 1 DM (Koda-Kimble 
and Carlisle, 2001). 
Following India, China has the second largest diabetic population in the world. The 
adult diabetic population in China was 20.8 million in 2000, which will increase to 42.3 
million by 2030 (Wild et al., 2004). In Hong Kong, diabetes is the eighth leading cause 
to death, accounting for 2% of death in 2001 (Department of Health, 2003). 
1,2 Definition of Diabetes Mellitus 
"Diabetes" and "Mellitus" are two words describing two well-known features of 
diabetic patients. The word “Diabetes，，refers to excessive urine excretion (polyuria), 
while “Mellitus” means the urine is "honeyed" (glycosuria). 
According to the report of World Health Organization (WHO) published in 1999, 
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the latest definition of diabetes mellitus is “a metabolic disorder of multiple aetiology 
characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and 
protein metabolism resulting from defects in insulin secretion, insulin action, or both" 
(World Health Organization, 1999). 
1.3 Glucose Homeostasis and Diabetes Mellitus 
Glucose is the major energy source of human body and transported to the whole 
body through the circulation system. Pancreas is the organ responsible for the regulation 
of blood glucose, by the action of two hormones: insulin and glucagon. The pancreas 
secretes insulin when blood glucose level is high, normally post-prandial, to inhibit the 
endogenous glucose production and stimulate the glucose utilization and storage. As the 
blood glucose decreases, insulin release is inhibited and the pancreas releases glucagon, 
as the counter-regulatory hormone, to maintain the basal glucose level. 
Insulin is the glucose lowering hormone secreted by P-cells in the islets of 
Langerhans of the pancreas. The islets of Langerhans are clusters of endocrine tissue 
scattered throughout the pancreas (Bonner-Weir, 1991). In addition to P-cells which are 
the most common cell type, the islets also contain glucagon-producing a-cells， 
somatostatin-producing 6-cells, and pancreatic polypeptide-producing PP-cells. Insulin 
is originated from proinsulin, a single-chain protein. A connecting peptide (C peptide) is 
cleaved from proinsulin to form insulin (Fig. 1.1). Insulin is a 51 amino acid 
polypeptide with two peptide chains connected by two disulphide bonds (Rhodes, 2004; 
Rhodes, 2004). 
Along with basal insulin release, P-cells store insulin in granules. Increase of blood 
glucose level causes depolarization of P-cells. This results in influx of calcium ion and 
exocytosis of insulin containing granules, called the first phase of insulin release. 
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Glucose also activates the protein kinase C, which is responsible for the sustained 
insulin release, called the second phase (Fig. 1.2) (Straub and Sharp, 2004). 
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5 53 52 50 49 
Fig. 1.1 Structure of Porcine Proinsulin. Insulin is originated from 
preproinsulin and proinsulin. After cleavage of connecting peptide (C peptide; 
white area) from proinsulin, two peptide chains A chain and B chain (grey area) 
connected by disulphide bonds and form 51 amino acid polypeptide insulin. 
Insulin is a 51 amino acid polypeptide with two peptide chains (Genuth, 1998). 
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Fig. 1.2 Model of insulin secreting pancreatic p-cell. Glucose is transported into 
pancreatic P-cell through glucose transporter 2 (GLUT2). Glucose is catalyzed to form 
gluocose-6-phosphate by glucokinase with a phosphate (from ATP) added. The 
generation of ATP by glycolysis and the Kerbs cycle leads to closure of the ATP-
sensitive K^ channels, which leads to depolarization of plasma membrane and 
extracellular calcium influx. This influxed calcium changed into intracellular storage. 
The insulin-containing secretory granules then fuse with plasma membrane and insulin 
is released into circulation (Bell and Polonsky, 2001). 
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1.4 Classification of Diabetes Mellitus 
The world Health Organization (WHO) has revised its ‘Definition, Diagnosis and 
Classification of Diabetes Mellitus and its Complications' in 1999 (World Health 
Organization, 1999). The revised classification criteria contain both the clinical stages 
and aetiological types of DM and other categories of hyperglycaemia. 
The clinical stages include normoglycaemia, impaired glucose regulation and 
diabetes mellitus. And aetiological classification refers defects, disorders or processes 
that lead to DM. Aetiological types contain type 1 diabetes mellitus (previously called 
insulin dependent diabetes mellitus), type 2 diabetes mellitus (previously called non-
insulin dependent diabetes mellitus), gestational diabetes mellitus and other specific 
types. 
1,4.1 Type 1 Diabetes Mellitus 
Type 1 DM is an autoimmune disease resulting from specific destruction of insulin-
producing p-cells of islet of Langerhans of the pancreas, and is characterised by 
absolute insulin deficiency (Tisch and McDevitt, 1996). It affects 0.5% of population in 
developing countries and increasing incidence (Mathis et al., 2001). There are 2 phases 
of Type 1 DM, the first is insulitis in which a mixed population of leukocytes invades 
the islets; while the second is diabetes in which most P-cells have been killed and no 
sufficient insulin can be produced for regulating circulating blood glucose level, and it 
leads to hyperglycaemia. 
There is an increasing risk of developing type 1 DM in first-degree relatives, 
especially on monozygotic twins. By studying the extensive sequencing of Major 
Histocompatibility Complex (MHC) class II alleles in man, it revealed that type 1 DM 
is closely interplayed with two major isotypes of MHC class II molecules HLA-DR and 
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HLA-DQ (Wicker et aL, 1995), and also the presence of antibodies against islet cells or 
glutamic acid decarboxylase (Koda-Kimble and Carlisle, 2001). 
Type 1 diabetes usually presents in children and adolescents, but it also occurs in 
elderly. Individuals who have type 1 diabetes depend on insulin therapy for survival 
(Ergun-Longmire et al., 2004). However, for the type 1 idopathic diabetic patients, they 
develop ketoacidosis without autoimmune destruction of the pancreas. Such traits are of 
unknown aetiologies and strongly inherited (Tiberti et al., 2000). 
1.4.2 Type 2 Diabetes Mellitus 
Type 2 DM is a heterogeneous disorder characterised by diminished liver, muscle, 
and adipose tissue sensitivity to insulin (insulin resistance) and impaired pancreatic /5 -
cell function (World Health Organization, 1999). Defects in insulin action can lead to 
impaired insulin secretion and vice versa, while impaired insulin secretion and 
hyperglycaemia can reduce insulin action. Also, when P-cells lose the ability to respond 
to glucose elevation after meal, insulin secretion is impaired and blood glucose level 
becomes out of control, then leading to Type 2 DM. The elevated blood glucose level 
may exist for many years before diagnosis, and result in damage of various target 
tissues before clinical symptoms. Genetic factor, obesity, sedentary lifestyle and aging 
are the believed risk factors of insulin resistance and type 2 DM (World Health 
Organization, 1999). 
Insulin resistance is defined as decreasing sensitivity of body tissue towards insulin, 
and it needs greater amount of insulin to elicit a normal response. Hyperinsulinaemia is 
a common feature in patients with an early insulin resistance. Insulin resistance is now 
known to be present at early stage of type 2 DM (American Diabetes Association, 1998). 
The symptoms of type 2 DM include fatigue, polyuria and polydipsia, but these are 
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usually mild and with gradual onset. Unexpected weight loss and ketosis are less 
common in type 2 diabetic patients. Individuals with type 2 diabetes do not need 
exogenous insulin for survival, although it may be required in patients with serious 
symptoms (Koda-Kimble and Carlisle, 2001). 
1.4.3 Gestational Diabetes Mellitus 
Hyperglycaemia during pregnancy is known as gestational diabetes mellitus 
(GDM). Women with GDM are at high risk of developing diabetes when they are not 
pregnant. Also, women who have GDM would have higher chances to develop type 2 
diabetes afterward (Buchanan et al., 1998; Xiang et al., 1999). 
1.4.4 Other specific types 
Only 1 to 2% of cases belong to this type of diabetes (Harris, 2004). Here is the 
list of different reasons resulting in diabetes: 
i) Genetic defects of P-cell function 
ii) Genetic defects in insulin action 
iii) Diseases of the exocrine pancreas 
iv) Endocrinopathies 
V) Drug or chemical induced 
vi) Infections 
vii) Uncommon forms of immune- mediated diabetes 
viii) Other genetic syndromes 
(World Health Organization, 1999) 
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1.5 Diagnostic Criteria of Diabetes Mellitus 
American Diabetes Association (ADA) revised the diagnostic criteria on 
diabetes mellitus in 2002 (refer to Table 1.1) (American Diabetes Association, 2004). It 
is based on the measure of hyperglycaemia by three criteria: basal plasma glucose level, 
fasting plasma glucose (FPG) and 2-hour post glucose load plasma glucose (oral 
glucose tolerance). Fasting plasma glucose level is the most commonly used diagnostic 
criteria for diabetes mellitus as it is easy to use, accepted by patients and with low costs. 
Fasting plasma glucose lower than 5.5 mM is considered as normal, while 7.0mM or 
above is considered as diabetes mellitus. Impaired fasting glucose (IFG) is plasma 
glucose level in between the two values. Oral glucose tolerance test (OGTT) is 
recommended if the result of FPG could not give the prominent result for diagnosis. The 
test is administrated in the morning after at least three days of unrestricted diet (greater 
then 150g of carbohydrate daily) and usual physical activity, followed by an overnight 
fasting of 8 to 14 hours. After collecting the fasting blood sample, the subject should 
drink 75g of anhydrous glucose in 250 to 300ml water within five minutes. Blood 
sample is collected after 2 hours, and plasma glucose level is determined (World Health 
Organization, 1999). Normal people should have a value smaller than 7.8mM, while 
diabetes patients have a result of 11.1 mM or above. IGT is diagnosed if the OGTT 
result is 7.8mM or above but smaller than 1 l.lmM. 
people without any obvious symptoms but shows hyperglycaemia in at least two 
test results is claimed to be diabetic patient. Moreover, hyperglycaemia detected under 
stress such as infection could not be regarded as diagnostic of DM. 
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Fasting p l a s m a O r a l glucose 
Basal plasma 
glucose tolerance test 
glucose 
(FPG) (2hr post glucose load) 
<100mg/dl <140 mg/dl 
Normal / 
(<5.5mM) (<7.7mM) 
Impaired 100-125 mg/dl 140-199 mg/dl 
/ 
glucose tolerance (5.6 — 6.9mM) (7.7 - l l . lmM) 
>200 mg/dl >126 mg/dl >200 mg/dl 
Diabetes 
(>l l . lmM) (>7.0mM) (>l l . lmM) 
Table 1.1 Diagnostic criteria of diabetes mellitus. Basal plasma glucose is defined as 
the plasma glucose level at any time of day. Fasting is defined as no caloric intake for at 
least 8 hours; Oral glucose tolerance test should be performed by using a glucose load 
containing the equivalent of 75g glucose dissolved in 250-300ml water (American 
Diabetes Association, 2004). 
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1,6 Complications of Diabetes Mellitus 
Complications could occur when the blood glucose level of the patients is not 
maintained at physiological range. The major risk factors for the marcovascular and 
microvascular complications of diabetes are hypertension, hyperlipidemia, 
hyperglycaemia, lack of exercise and smoking. Most of these risk factors are more 
prevalent in the type 2 diabetic population and synergistically to promote vascular 
disease. 
Here are the common diabetic complications: 
Cardiovascular complications - It includes coronary heart disease and strokes, are 
the most common cause of morbidity and mortality in diabetes. Its occurrence is 
positively associated with duration of diabetes (Resnick et aL, 2004). Hyperglycaemia 
promotes the formation of advanced glycosylaton (glycation) products, which cross-link 
with collagen, causing arterial stiffness. Atherogenesis would appear as increased levels 
of low-density lipoprotein (LDL) cholesterol (Bate and Jemms, 2003). 
Retinopathy - Up to 12% of type 1 and 5% of type 2 diabetic patients become 
blind after 30 years of diabetes because of diabetes retinopathy or cataract (Chew, 2004; 
Watkins et al., 2003). It is due to hemorrhages and angiogenesis in the retina leading to 
damaged vision (Ewing et al., 1998). 
Nephropathy - Diabetes could damage the glomeruli of the kidney and decrease 
the glomerular filtration rate, leading to proteinuria and hypemricaemia (National 
Institute of Diabetes and Digestive and Kidney Diseases, 1995). It affects 20-40% of 
the diabetic patients, for some case kidney transplantation are needed (Ruggenenti and 
Remuzzi, 2000). 
Neuropathy - It has a wide variety of manifestation in diabetic patients, and these 
neuropathies are among the most common and perplexing complications of diabetes 
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mellitus (American Diabetes Association, 1998). More than half of diabetic patients 
develop neuropathy (Feldman, 2003) and it is clear that impaired blood flow and 
endoneurial hypoxia are the major causes (Cameron et al., 2001). Peripheral and 
autonomic nerve dysfunction would cause a painful syndrome, featuring numbness, 
diarrhea, postural hypotension, respiratory arrests, sweating and erectile dysfunction 
(Watkins et a/.，2003). 
Foot ulcer - For diabetes patients, foot ulcer and amputation are the major cause 
of morbidity and disability (Frykberg et al., 1998). Foot lesions are commonly found on 
the patient's foot, and about 15% of the diabetic patients will develop foot ulcer 
(Edmonds and Foster, 2004). Polyneuropathy, peripheral vascular disease, 
superimposed infection or a combination of these complications would cause numbness 
and ischaemia of foot, and gradually develop into foot ulcer (American Diabetes 
Association, 1998). Unhealing ulceration usually leads to amputation in the worst cases 
(Watkins et al., 2003). Current therapy is mainly performed by applying antibiotics and 
intensive wound care (Edmonds and Foster, 2004; Mason et al., 1999). 
1,7 Pharmacological Treatment of Diabetes 
The management goals of diabetes mellitus are mainly to achieve normal glyceamic 
control, and it is the key to prevent long-term complications, so as to improve the 
quality of life of the patients. There are three main kinds of treatments for different 
types of diabetes mellitus: dietary modification, regular physical activity and 
pharmacological approach with either oral hypoglycaemic agents or insulin. 
1.7.1 Treatment for type 1 diabetes mellitus 
Exogenous insulin is the only option currently available as replacement therapy to 
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compensate for the lack of endogenous insulin in type 1 DM. Insulin could decrease the 
blood glucose level by promoting glucose uptake from blood into target cells 
(adipocytes, hepatocytes and also skeletal muscle cells) which is responsible for 
carbohydrates, lipid and protein metabolism. At the cellular level, insulin could 
stimulate glycogen synthesis, lipid synthesis and glucose oxidation, while it could also 
inhibit glycogenolysis, lipolysis and gluconeogenesis. 
Exogenous insulin is absorbed through the circulation system after subcutaneous 
injection, and the patients need to inject insulin around 4 times per day and 30 minutes 
before meal, in order to match the physiological peak of insulin secretion of normal 
people (American Diabetes Association, 1998). 
There are many adverse effects of insulin injection, such as hypoglycaemia (due to 
hyperinsulinemia), lipodystrophy (cause allergic reaction on injection site), defective 
counter-regulatory hormonal response and weight gain (Koda-Kimble and Carlisle, 
2001). Hence, various insulin analogues were produced (insulin lispro, insulin aspart, 
insulin glargine and insulin detemir) to overcome the hypoglycaemic effect by altering 
the onset and duration period (Dunn and Plosker, 2002; Gillies et al., 2000; Goldman-
Levine and Lee, 2005; Simpson and Spencer, 1999). 
Pancreas or pancreatic islets transplantation is another method to overcome long-
term insulin injection and also daily inspection on blood glucose for type 1 diabetic 
patients (Burke et al., 2004). However, the success rate of transplantation is relatively 
low as chronic rejections and recurrence of autoimmunity may occur (Lohmann et al., 
2002). 
1.7.2 Treatment for Type 2 diabetes mellitus 
Type 2 diabetic patients usually suffer from insulin resistance or insulin deficiency 
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or both. Hence insulin therapy could not be used in this case. Dietary control and 
exercise may help to control blood glucose for each meal and exercise could improve 
the state of insulin resistance (increasing insulin sensitivity) of muscle cells and 
adipocytes. By means of these methods, body weight could be controlled and increase 
glucose uptake by muscle cells and adipocytes. 
However, oral anti-diabetic drugs could be applied if non-medication treatments do 
not work. These drugs act on the target tissues which are involved in glucose 
metabolism by different modes of action: i) stimulating insulin release; ii) inhibiting 
hepatic gluconeogenesis; iii) inhibiting glucose absorption from intestine; and iv) 
improving insulin sensitivity of peripheral tissues. Insulin may be used when blood 
glucose is not under control even if oral medications are applied. 
There are five classes of anti-diabetic drugs nowadays, namely sulfonylureas, 
meglitinides, biguanides, thiazolidinediones and a-glucosidase inhibitors. 
1.7.2.1 Sulfonylureas 
Sulfonylureas stimulate the pancreatic P-cells to release more insulin (Zimmerman, 
1997). Sulfonylureas could bind onto specific sulphonylurea receptors on the pancreatic 
p-cells. Such binding results in inhibition of ATP-dependent K+ channel and cause 
depolarization of the plasma membrane by calcium ion (Ca^^) influx due to intracellular 
K+ increases. Finally, insulin is released from insulin-containing granules (Chehade and 
Mooradian, 2000). 
The most common side effects of sulfonylureas are hypoglycaemia (Bayraktar et al., 
1996; Lam et al., 1998) and weight gain (Kabadi and Kabadi, 2003). The drugs (except 
glyburide) are also not suitable for pregnant or breast-feeding women because they can 
cross the placenta and can be excreted into breast milk (Koda-Kimble and Carlisle, 
2001). 
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Some examples of sulfonylureas are glimepiride, glyburide, chorpropamide, 
acetohexamide, glipizide, glyburide, tolbutamide and tolazamide (American Diabetes 
Association, 1998). 
1,7.1.2 Meglitinides 
Meglitinidies also stimulate pancreatic (3-cells to release insulin. Its action is faster 
then sulfonylureas as it has rapid onset and short duration, hence it should be 
administrated shortly after the meal (Fuhlendorff et al., 1998). It has potent oral 
hypoglycaemic activity and is structurally different from the sulphonylureas, although it 
stimulates Ca^^ influx by binding to the different receptor sites compared with 
suphonylurea on pancreatic p-cells and closing ATP-dependent K+ channels (Adis 
International Limited, 2004; Dunn and Faulds, 2000). 
It is important in reducing long-term cardiovascular complications of diabetes. Its 
side-effects are hypoglycaemia and weight gain, but not as serious as sulfonylureas do 
(Plosker and Figgitt, 2004). Examples of meglitinides are repaglinide and nateglinide 
(American Diabetes Association, 1998). 
1.7.1,3 Biguanides 
Biguanides were developed from a traditional plant remedy, Galega officinalis 
(French Lilac, goat's rue). Guanidine is the plant extract proved to have mild 
antidiabetic activity in 1918. But due to its toxicity and pathological effects, it is not 
suitable for clinical use (Keeler et al., 1992). 
Phenformin and metformin were then developed, but nowadays only metformin 
was used as because phenformin showed lethal side-effect and lactic acidosis (Bailey, 
1992). Metformin reduces blood glucose by means of enhancing the glucose uptake by 
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skeletal muscle cells and adipocytes through glucose transporter type 4 (GLUT4). It 
also exerts effects on hepatocytes to inhibit the hepatic gluconeogenesis, so as to lower 
the fasting blood glucose level. Metformin increases insulin sensitivity but only with the 
presence of insulin in the patients as well (Bailey, 1992; Bailey and Turner, 1996). 
However, metformin would cause lactic acidosis, hence it could not be used on 
patients who has renal impairment (Bailey and Turner, 1996). 
1.7.1.4 Thazolidinediones 
Thiazolidinediones (TZDs) is a new class of antidiabtic drugs which known as 
peroxisome proliferators-activated receptor-gamma (PPAR-y) agonists (Krentz et al., 
2000). PPAR-y is a transcription factor that is found mainly in adipose tissues (Vidal-
Puig et al., 1997). It lowers the blood glucose level by increasing insulin sensitivity in 
skeletal muscle and adipocytes (Kim et al., 2004a), thus insulin-stimulated signal 
transduction is enhanced (Miyazaki et al., 2003). 
Ciglitazone was the first TZD derivatives, and then followed by troglitazone, 
pioglitazone，rosglitazone and englitazone (Saltiel and Olefsky, 1996). Troglitazone was 
the first discovered TZD but due to hepatotoxic effect, it was soon stopped in the market 
(Graham et al., 2003). 
The major adverse effects of TZDs are weight gain, hepatocytotoxity, edema and 
anemia (Lebovitz, 2002). Recently TDZs was also discovered to cause congestive heart 
failure (Cheng and Fantus, 2004). 
1.7.1.5 a-Glucosidase inhibitor 
a-Glucosidase is an enzyme which locates in brush border of the small intestine 
and is responsible for breaking down non-absorbable carbohydrates into absorbable 
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monosaccharides. a-Glucosidase inhibitors are reversible competitive inhibitors of this 
enzyme. Acarbose is one of the most commonly used a-glucosidase inhibitors (Bischoff, 
1994). 
Acarbose mainly exerts its antidiabetic function by reversibly inhibit a-glucosidase 
by binding to the active site of the enzyme, and preventing its cleavage of substrate 
(complex carbohydrates) (Salvatore and Giugliano, 1996). Thus, it could slow down the 
absorption of carbohydrates from intestine of the patients, and lower the postprandial 
blood glucose level. But acarbose has no effect on monosaccharides which do not need 
to be cleavaged by a-glucosidase (Yee and Fong, 1996; Bischoff, 1994). 
Gastrointestinal disturbance such as flatulence, abdominal distension and diarrhea 
may occur because of the presence of undigested complex carbohydrates in the colon if 
the dosage of the drug is low (Chiasson et al., 1994). Moreover, using acarbose at a 
dose larger than 300 mg/day could cause liver damage (Coniff et al., 1995). 
1.8 Diabetes and Traditional Chinese Medicine 
In Chinese medical pathology, diabetes mellitus is defined as "Xiao Ke Zhang"(消 
渴症).Patients who suffered from “Xiao Ke Zhang” would have thirsty feeling, sweet 
urine and weight loss. This is due to the deficiency of Yin (陰）and heat inside stomach, 
kidney and lung, leading to water loss. Traditional Chinese medical expert book "Huang 
Di Nei Jing"(黃帝內/經)claimed that diabetes is resulted from long-term intake of fatty 
and sweet food. The treatment of "Xiao Ke Zhang" is mainly nourish yin, restoring 
water content inside body by clearing heat, and also tonifying Qi (氣).Many traditional 
Chinese medicines (TCMs) have been used for treatment of diabetes mellitus. A survey 
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was done by my colleague Dr. David Lau among the traditional Chinese herbal 
formulae in treating diabetes mellitus (see Appendix 1). 
1.9 Objective of this project 
Type II diabetes mellitus is a chronic metabolic disorder with increasing prevalence. 
Many western oral medications have been developed for treatment, but most of them 
have side effects, and cause serious kidney failure with long-term application. 
Traditional Chinese herbs which have fewer side effects could be an alternative means 
for diabetes control. 
Fourteen herbs were selected from the traditional Chinese herbal formulae (Table 
1.2), according to their frequency of usage and also the dosage indicated in the list 
mentioned above (Appendix 1). Various in vitro models for intestinal glucose 
absorption, hepatic glucose production and cellular glucose uptake were used to screen 
the selected herbs for their potential anti-diabetic effects. Herbs showing promising 
effects in vitro were further investigated in vivo using diabetic rat model. 
There were three herbs chosen from formula 1 "Tuo Du Sheng Ji Tang"(托毒生肌 
湯）and formula 2 “Qi Wei Di Huang Tang"(耆味地黃湯)，namely Cortex Moutan (牡 
丹皮)，Rhizoma Smilacis Chinensis (菝葜）and Rhizoma Alismatis (澤蕩)，they all 
showed the most potent anti-diabetic effects in various in vitro assays done by another 
two students (Chan, 2004; Lau, 2004). Formula 1 and formula 2 were developed for 
treating diabetic foot ulcer by a Chinese herbalist in order to prevent amputation in type 
2 DM patients (Wong et al., 2001). The ingredients of both formulae are shown in table 
1.3. As the chosen herbs showed potent anti-diabetic effects in vitro, the results were 
confirmed by in vivo model. 
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Furthermore, bioassay-guided fractionation of Paeonia suffruticosa (牡丹皮)was 
employed in order to isolate the active component(s) and the chemical structure(s) was 
elucidated. 
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Latin Name Chinese Name 
Paeonia lactiflora Pall. 白苟 
Platyclatus orientalis (L.) Franco 柏子仁 
Codonopsis pilosula (Franch.) Nannf. 黨參 
Lophatherum gracile Brongn. 淡竹葉 
Glycyrrhiza uralensis Fisch. V i ^ 
Pueraria lobata (Willd.) Ohwi B ® 
Cinnamomum cassia Presl 
Phellodendron amurense Rupr. 黃柏 
Coptis chinensis Franch. 黃連 
Ophiopogon japonicus (L.f.) Ker-Gawl. 麥冬 
Trichosanthes kirilowii Maxim. 天花粉 
Pseudostellaria heterophylla (Miq.) Pax ex Pax et Hoffm. 太子參 
Ziziphus jujuha Mill. var. spinosa (Bunge) Hu ex H. F.Chou 棗仁 
Anemarrhena asphodeloides Bge. 矢口母 
Table 1.2 Fourteen herbs were selected according to survey in Appendix 1. 
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Formula 1 
Radix Astragali ^ 
Radix Polygoni Multiflori Preparata 制首烏 W 
Radix Rehmanniae 生地黃 9g 
Radix Stephaniae Tetrandrae 漢防已 9g 
Rhizoma Atractylodis Marcocephala 白 jft 9g 
Rhizoma Smilacis Chinensis 菝葜 9g 
Formula 2 
Cortex Moutan 牡丹皮 ^ 
Fructus Comi 山茱萸 ^ 
Fructus Schisandrae Chinensis 五味子 6g 
Poria ^ ^ 
Radix Astragali S S ^ 
Radix Rehmanniae 生地黃 12g 
Rhizoma Alismatis 澤篇 6g 
Rhizoma Dioscoreae P u S W 
Table 1.3 The herbal ingredients of Formula 1 and Formula 2. 
(Wong et a/., 2001) 
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Chapter 2 Botanical， Preparation and 
Authentication of Traditional Chinese Herbs 
2,1 Introduction 
In this chapter, the background and properties of each selected herbs will be 
mentioned, also authentication of each herbs will be discussed. 
As last chapter mentioned, the purpose of my project is to select some 
traditional Chinese herbs other then Formula 1 ‘‘Tuo Du Sheng Ji Tang，,and Formula 
2 “Qi Wei Di Huang Tang，，，then investigate the synergistic effect of the effective 
herbal extracts in treating diabetes mellitus. 
The three herbs that showed significant effects in in vitro assays in Formula 1 
and Formula 2 are chosen for further studies (Wong et al., 2001); they are Cortex 
Moutan, Rhizoma Smilacis Chinensis and Rhizoma Alismatis. And for the other 14 
herbs chosen from 12 traditional herbal formulae (Table 1.2); they were selected 
according to their frequency and dosage used. 
2.2 Herbal Materials 
In this part, the information of Chinese medicinal properties and some research 
findings regarding on the function of each traditional herb will be discussed. 
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Cortex Moutan (牡丹皮） 
Cortex Moutan (Mudanpi) is the dried root bark of Paeonia suffruticosa of the 
family Ranunculaceae. It is used to remove heat from blood, to activate blood 
circulation and eliminate blood stasis (State Pharmacopoeia Commission, 2000). 
Recent studies found that polysaccharides isolated from Cortex Moutan possessed 
hypoglycaemic effect on alloxan-induced diabetic mice and streptozotocin (STZ, 
also known as streptozotocin) -induced diabetic rats (Wang et al., 2001; Hong et al., 
2003) 
Rhizoma Smilacis Chinensis (蔬葜� 
Rhizoma Smilacis Chinensis is the dried rhizome of Smilax china L. [S. 
japonica]. It is usually used to treat rheumatic disease, dysentery and upset stomach 
(State Pharmacopoeia Commission, 2000). It is also found to have diuretic action and 
promotional effect on blood circulation (Liu et al., 2002). No report concerning the 
effects of this herb on diabetes has been published. 
Rhizoma Alismatis (澤瀉） 
Rhizoma Alismatis (Zexie) is the dried tuber of Alisma oriental is of the 
family Alismataceae. In TCM theory, its action is to cause diuresis, and to remove 
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damp-heat (State Pharmacopoeia Commission, 2000). Water-ethanol extract of 
Rhizoma Alismatis was found decreasing plasma glucose and triglycerides, and 
increasing plasma insulin of alloxan-induced and STZ-induced diabetic mice (Yang 
et al., 2002a; Yang et al., 2002b). 
Radix Paeoniae Alba (白苟） 
Radix Paeoniae Alba (Baishao) is the dried root of Paeonia lactiflora (Family 
Ranunculaceae). It is used to subdue hyperactivity of the liver and relieve pain, to 
nourish blood and regulate menstruation, and to check excessive perspiration (State 
Pharmacopoeia Commission, 2000). 
Semen Platvcladi (柏子仁） 
Semen Paeoniae Alba (Baiziren) is the dried ripe kernel of Platycladus 
orientalis (L.) Franco (Family Cupressaceae). It is commonly used to calm the 
nerves, to check excessive peripiration, and to relax the bowels (State Pharmacopoeia 
Commission, 2000). No diabetes related research of this herb has been done. 
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Radix Codonopsis (黨參、 
Radix Codonopsis (Dangshen) is the dried root of Codonopsis pilosula 
Franch. (Family Campanulaceae). According to TCM theory, it is used to reinforce 
Qi and invigorate the function of spleen and the lung. It is commonly used to treat 
diabetes caused by internal heat (State Pharmacopoeia Commission, 2000). No 
diabetes related research of this herb has been done. 
Herba Lophatheri (淡竹葉） 
Herba Lophatheri (Danzhuye) is the dried stem and leaf of Lophatherum 
gracile Brongn. (Family Gramineae). It is used to remove heat, ease the mind and 
cause diuresis (State Pharmacopoeia Commission, 2000). No diabetes related 
research of this herb has been done. 
Radix Glvcvrrhizae (甘草） 
Radix Glycyrrhizae (Gancao; licorice) is the dried root and rhizome of 
Glycyrrhiza uralensis Fisch. (Family Leguminosae). It can reinforce the function of 
the spleen and the stomach marked by lassitude and weakness, cardiac palpitation 
and shortened of breath, cough with much phlegm, spasmodicsores. It is often used 
for reducing the toxic or drastic strength, arrhythmia (State Pharmacopoeia 
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Commission, 2000). The ethanolic extract of Glycyrrhiza uralensis (100 to 300 
mg/kg) could drcrease blood glucose level in younger (6 wk old) and older (13 wk 
old) diabetic KK-Ay mice (Mae et al., 2003). Also, Glycyrin, one of the main PPAR-
Y ligands of licorice, significantly decreased the blood glucose levels of genetically 
diabetic KK-Ay mice (Kuroda et al., 2003). 
Radix Puerariae (葛根） 
Radix Puerariae is the dried root of Pueraria lobata Willd. (Famiy 
Leguminosae). It can be used to relieve fever, to promote the production of body 
fluid, to facilitate eruption, and to arrest diarrhea. It is a well-known herb which 
commonly used to treat diabetes (State Pharmacopoeia Commission, 2000). Puerarin, 
an active component in Radix Puerariae, can increase the glucose utilization to lower 
plasma glucose in diabetic rats lacking insulin (Hsu et al., 2003). Pueraria lobata 
also has many other applications, such as anti-oxidant, anti-tumor, healing 
cardiovascular disease etc. 
Ramulus Cinnamorni (桂枝） 
Ramulus Cinnamorni is the dried young branch of Cinnamomum cassia 
(Family Lauraceae). It is used to induce perpiration, to warm the channels and 
Chapter 2 Botanical, Preparation and Authentication of Traditional Chinese Herbs 26 
stimulate menstrual discharge, to reinforce yang, to relieve palpitation, and to 
promote the decending of qi (State Pharmacopoeia Commission, 2000). A decrease 
in blood glucose levels was observed in a glucose tolerance test (GTT) in rat model 
after applying Cinnamomum cassia extract; furthermore, the elevation in plasma 
insulin was direct since a stimulatory in vitro effect of insulin released from INS-1 
cells (an insulin secreting cell line) was observed (Verspohl et al., 2005). 
Cortex Phellodendri (黃柏） 
Cortex Phellodendri is the dried root of Phellodendron amurensQ Rupr. 
(Family Rutaceae). It is used to remove damp-heat; quench fire, counteract toxicity, 
and relieve consumptive fever (State Pharmacopoeia Commission, 2000). No 
diabetes related research related to this herb has been done. 
Rhizoma Coptidis (黃連） 
Rhizoma Coptidis is the dried rhizome of Coptis chinensis Franch. (Family 
Ranunculaceae). It is used to remove damp-heat, quench fire and counteract toxicity 
(State Pharmacopoeia Commission, 2000). Crude extract of Rhizoma Coptidis could 
decrease the serum glucose level in normal mice. A study showed that berberine, the 
major component in Rhizoma Coptidis, had an anti-hypoglycemic effect in normal, 
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alloxan-induced, and spontaneous diabetic KK mice. It could also suppress the 
hyperglycemic effect induced by intraperitoneal injection (i.p.) of glucose in normal 
mice, reduced the cholesterol level of the mice and also inhibit the aggregation of 
rabbit platelet in vitro (Chen and Xie, 1986). A recent study also showed that it could 
cause apoptosis on human colorectal cancer cells in vitro (Chen and Xie, 1986; Kim 
et aL, 2004b). 
Radix Ophiopogonis (麥冬） 
Radix Ophiopogonis is the dried root tuber of Ophiopogon japonicus Thunb. 
(Family Liaceae). It is used to nourish yin and promote the production of body fluid, 
to moisten the lung, and to ease the mind. It can be used to treat diabetes caused by 
internal heat (State Pharmacopoeia Commission, 2000). A study showed that it had a 
hypoglycaemic effect on streptozotocin-induced diabetic mice (Kako et al., 1995). 
Polysaccharides of Radix Ophiogonis had an anti-hyperglyceamic activity on 
alloxan-induced diabetic mice (Zhang and Wang, 1993). 
Radix Trichosanthis (天花粉） 
Radix Trichosanthis is the dried root of Trichosanthes kirilowii Maxim 
(Family Cucurbitaceae). It is to remove heat, to promote the production of body fluid, 
Chapter 2 Botanical, Preparation and Authentication of Traditional Chinese Herbs 28 
and to facilitate the drainage of pus and subsidence of swelling. It can be used to treat 
diabetes caused by internal heat (State Pharmacopoeia Commission, 2000). Study 
proved that five glycans trichosans A, B, C, D and E showed hypoglycemic actions 
in normal mice. The main glycan, trichosan A, also exhibited activity in alloxan-
induced hyperglycemic mice (Hikino et al., 1989). 
Radix Pseudostellariae (太子參） 
Radix Pseudostellariae is the dried root tuber of Pseudostellaria heterophylla 
Miq. (Family Caryophyllaceae). It is to replenish qi and invigorate the spleen 
function, and to promote fluid secretion and moisten the lung (State Pharmacopoeia 
Commission, 2000). Pseudostellaria heterophylla exhibits both immunomodulatory 
and anti-tumor activities(Wong et al., 1994), but no related studies is done on its 
anti-diabetic effect. 
Rhizoma Anemarrhenae (知母） 
Rhizoma Anemarrhenae is the dried rhizome of Anemarrhena asphodeloides 
Bge. (Family Liliaceae). It removes heat and quenches fire, and promotes the 
production of body fluid and relieves the dryness syndrome. It can be used to treat 
diabetes due to internal heat (State Pharmacopoeia Commission, 2000). Study 
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showed the water extract of Radix Ophiopogonis (90mg/kg) could reduce the blood 
glucose level after oral administration (Miura et al., 2001b), also its active 
component mangiferin and mangiferin-7-O-P-D-glucoside exerted an anti-diabetic 
effect by increasing insulin sensitivity (Miura et al., 2001a; Miura et al., 2001b). 
Semen Ziziphi Spinosae (棗仁） 
Semen Ziziphi Spinosae is the dried ripe seed of Ziziphus jujuba Mill. 
(Family Rhamnaceae). It is used to replenish the liver, to cause tranquilizations, to 
arrest excessive perspiration, and to promote the production of body fluid (State 
Pharmacopoeia Commission, 2000). No diabetes related research has been done 
using this herb. 
2.3 Authentication of Herbal Material 
All 17 selected herbs were purchased from a local supplier in Hong Kong and 
authenticated by a morphological expert, Dr. Cao Hui (National Engineering 
Research Center for Modernization ofTCM, Zhuhai, Guangdong, China). Herbarium 
voucher specimens were deposited at the museum of the Institute of Chinese 
Medicine, the Chinese University of Hong Kong, with the voucher specimen 
numbers shown in Table 2.1. 
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� . „ L Voucher Specimen Chinese Herbs [   Numbers  
Cortex Moutan (牡丹皮） 2003-2456 
Rhizoma Smilacis Chinensis (菝葜） 2003-2463 
Rhizoma Alismatis (澤篇） 2003-2455 
Radix Paeoniae Alba (白与） 2005-2632 
Semen Platycladi (柏子仁） 2005-2629 
Radix Codonopsis (黨參） 2005-2628 
Herba Lophatheri (淡竹葉） 2005-2634 
Radix Glycyrrhizae (甘草） 2005-2623 
Radix Puerariae (葛根） 2005-2630 
Hamulus Cinnamomi (桂枝） 2005-2631 
Cortex Phellodendri (黃柏） 2005-2624 
Rhizoma Copitidis (黃連） 2005-2587 
Radix Ophiopogonis (麥冬） 2005-2625 
Radix Trichosanthis (天花粉） 2005-2626 
Radix Pseudostellariae (太子參） 2005-2627 
Rhizoma Anemarrhenae (知母） 2005-2633 
Semen Ziziphi Spinosae (棗仁） 2005-2635 
Table 2.1 Voucher specimen numbers of seventeen Chinese herbs 
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2.4 Extraction Method 
2.4.1 Material and Methods 
Each herb was sliced into small pieces, and the weight was recorded before 
extraction. 200ml distilled water was added per 50mg herb, then refluxed for two 
hours. Extracted solution was collected and the herb was refluxed for two more hours 
with fresh 200ml distilled water, and a second extracted solution was collected. The 
two extracted solutions were combined together, centrifuged at 13000xg for 15 
minutes, the supernatant was then collected and frozen at -80°C. The frozen solution 
was completely dried by freeze-drier and stored in desiccators. The weight of dried 
extract was recorded and the extraction yield was calculated. 
2.4.2 Results 
The percentage yield of each herb was shown in Table 2.2. The percentage yield 
of the herbs varied greatly from 13.87 % to 44.96%. 
2.4 Discussion 
Cortex Moutan, Rhizoma Smilacis Chinensis, Rhizoma Alismatis，Radix 
Glycyrrhizae, Radix Puerariae, Ramulus Cinnamomi, Rhizoma Coptidis, Radix 
Ophiopogonis, Radix Trichosanthis, Radix Pseudostellariae and Rhizoma 
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Anemarrhenae are published to have anti-diabetic effects (Li et al., 2004b). As the 
active component(s) and the mode of actions of anti-diabetic effect of some herbs are 
unclear, further investigations including in vitro and in vivo studies are needed. 
The raw herbs mentioned above were authenticated before any pharmacological 
studies were carried out. All of them have been proved to be genuine by an expert on 
plant morphology. 
In the next 3 chapters, in vitro assays, in vivo assays and purification of active 
component(s) from the most potent anti-diabetic herbs will be discussed. 
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Chinese Herbs Percentage Yield (%) 
Cortex Moutan (牡丹皮) 21.00 
Rhizoma Smilacis Chinensis (蔬葜） 25.53 
Rhizoma Alismatis (澤潟) 
Radix Paeoniae Alba (白苟) 
Semen Platycladi (柏子仁) 
Radix Codonopsis (黨參) 
Herba Lophatheri (淡竹葉) ^ 
Radix Glycyrrhizae (甘草） 33.74 
Radix Puerariae (葛根) 
Ramulus Cinnamorni (桂枝） 30.67 
Cortex Phellodendri (黃柏) 
Rhizoma Copitidis (黃連) 4 0 ^ 
Radix Ophiopogonis (麥冬) 44.96 
Radix Trichosanthis (天花粉) ^ 
Radix Pseudostellariae (太子參) 26.20 
Rhizoma Anemarrhenae (知母） 37.52 
Semen Ziziphi Spinosae (棗仁） 26.65 
Table 2.2 The extraction yield of seventeen selected herbs. 
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Chapter 3 In vitro Studies on Selected 
Traditional Chinese Herbs 
3.1, Introduction 
As mentioned in chapter 1, the pharmacological actions on anti-diabetes 
mainly focus on four actions: 
a) Increasing insulin secretion; 
b) Enhancing glucose utility in peripheral tissue and adipocyte; 
c) Suppressing hepatic gluconeogenesis; and 
d) Inhibiting carbohydrates uptake from intestine. 
The first mechanism mainly targeted on the insulin deficiency problem in type 2 
DM due to P-cell dysfunction; the second and third mechanisms were focused on 
insulin resistance of target tissues and so to improve glucose homeostasis; and 
finally the forth mechanism targeted on impaired glucose tolerance in type 2 DM by 
preventing postprandial surge of blood glucose level, and together with insulin 
resistance and impaired P-cell function (Li et al., 2005). Most of the western drugs 
have been developed to exert their anti-diabetic effects based on these four 
mechanisms (Anjana Patel, 2003). My project will focus on the anti-diabetic effects 
of traditional Chinese herbs under these four mechanisms. 
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Four in vitro assays were chosen to demonstrate the anti-diabetic effects of 
each herb: 
i) Human skin fibroblast Hs68 and mouse adipocyte 3T3-L1 - to 
investigate the enhancing effect of herbal extract on glucose 
uptake into peripheral tissues. 
ii) Rat hepatoma cell H4IIE - to investigate the inhibition of 
herbal extract on hepatic gluconeogenesis. 
iii) Rabbit brush border membrane vesicle (BBMV) - to 
investigate the suppressing effect of herbal extract on glucose 
absorption into intestine. 
The relationship of these four in vitro models in anti-diabetic studies of the 
herbs will be discussed below in this chapter. 
3.2 Hepatic Gluconeogenesis Studies 
3.2.1 Introduction 
The liver plays a central role in controlling glucose homeostasis by 
gluconeogenesis (glucose production) and glycolysis (breakdown of glucose). 
Gluconeogenesis is the synthesis of glucose from non-carbohydrate precursors 
(pyruvate, lactate, glycerol and amino acids). It is very important to maintain brain 
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glucose level. In a longer period starvation, glucose must be formed from non-
carbohydrate sources for survival. 
Three essential enzymes play important role in gluconeogenesis, namely glucose 
6-phosphatase (G-6-Pase), fructose 1,6-bisphosphatase (F-l,6-BPase) and 
phosphoenolpyruvate carboxylkinase (PEPCK). The process of gluconeogenesis is 
shown in Fig. 3.1 (Stryer L, 1995). 
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Fig. 3.1 The Gluconeogenesis Pathway. There are three major enzymes in 
gluconeogenesis, including phosphoenolpyruvate carboxykinase (PEPCK), fructose-
1,6-bisphosphatase and glucose-6-phosphatase (Stryer L，1995). 
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The blood glucose level at fasting stage is mainly maintained by glucose 
produced by liver, over 80% of blood glucose was released by glycogenolysis and 
gluconeogenesis (Stumvoll et al., 1997), but in postprandial state, hepatic glucose 
output is suppressed by nearly 80% (Selz et al., 2003). In type 2 diabetic patients, 
insulin resistance would lead to an increase of hepatic glucose output and blood 
glucose level as insulin could not exert its effect on controlling gluconeogenic 
enzymes (Barthel and Schmoll, 2003). Besides, during fasting state, basal hepatic 
glucose production is increased by 30% (Beck-Nielsen et al., 2002; Staehr et al., 
2002). In postprandial state suppression of hepatic glucose output is lowered by 50% 
as excessive glucose is produced by gluconeogenesis in those patients (DeFronzo, 
1999). 
According to the above evidence, the study of inhibitory effect of drugs on 
hepatic gluconeogenesis can reveal the mode of action in diabetes treatment. 
Metformin is the most commonly used drug in treating abnormal hepatic glucose 
production in type 2 diabetic patients (Perriello et al., 1994; Stumvoll et al., 1995). 
H4IIE was used in this study, it is a cell line developed from rat hepatoma (Reauber, 
1961； Pitot et al., 1964). Moreover, the glucose produced by H4IIE could not be 
metabolized nor stored as glycogen, hence it is commonly used in gluconeogenesis 
study (Riu et al., 1996). H4IIE retains the ability to convert lactate and pyruvate to 
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glucose, by expressing gluconeogenic enzymes including glucose-6-phosphatase (G-
6-Pase) and phosphoenolpyruvate carboxykinase (PEPCK). It also responses to 
various hormones such as insulin (which suppresses gluconeogenesis), adenosine 
3,,5,-cyclic monophosphate (cAMP) and dexamethasone (which induce 
gluconeogenesis) (Wang et al., 2000; Hombuckle et ah, 2001; Sasaki et al., 1984). 
G-6-Pase catalyzes the hydrolysis of glucose-6-phosphate (G-6-P) to glucose, 
which is the terminal step of hepatic gluconeogenesis and glycogen breakdown. G-6-
Pase is induced in staved or diabetic animals (Nordlie et al., 1999). A suitable anti-
diabetic agent should have actions similar to insulin, and bypass the defects in insulin 
action characterized by insulin resistance (Schmoll et al., 2000). 
In this study, glucose production assay was applied to study the inhibitory effect 
of TCM. Dexamethasone and 8-(4-chlorophenylthio)-cAMP (pCPT-cAMP, a non-
metabolized derivative of cAMP) were added to stimulate the gluconeogenic activity 
in H4IIE. Insulin was added in the assay as positive control as it could counteract the 
glucose production effect. As effective anti-diabetic agents should have a similar 
action compare to insulin, herbal water extracts were added in different 
concentrations in order to mimic the effect of insulin, and their inhibitory effects in 
gluconeogenesis were studied. Glucose produced was measured by the glucose 
oxidase method (Wang et al., 2000; Waltner-Law et al., 2002). 
Chapter 3 In vitro Studies on Selected Traditional Chinese Herbs 40 
3.2.2 Materia丨 and Methods 
3.2.2.1 Cell Culture of H4IIE 
Rat hepatoma cell line H4IIE (American Type Culture Collection, ATCC, 
Manassas, VA, USA) was cultured in Dulbecco's modified Eagle's medium ( D M E M ) 
(supplemented with 4500mg/L D-glucose, 4 m M L-glutamine, llOmg/L sodium 
pyruvate and 4mg/L pyridoxine HCl, pH.7.4), with 10% v/v fetal bovine serum 
(FBS), 5 ml streptomycin (100|Lig/ml) and penicillin (100 unit/ml) mixture solution. The 
cells were allowed to grow in a humidified incubator at 37°C with 5% CO2. The 
medium was changed two to three times a week and cells were subcultured when the 
density reached 70% to 80%. Subcultivation was made by first removal of all the 
medium inside the culture flask, and a rinse with 10ml phosphate buffered saline (PBS, 
containing 137mM NaCl, 2.7mM KCl, 1.5mM KH2PO4, S.lmM Na2HP04, pH7.4). 
The solution was removed and 1 to 2 ml of trypsin-EDTA solution was added. The 
flask was allowed to sit at 37°C incubator for five minutes until the cells detach. Five 
mililitres of fresh D M E M was added to stop the reaction, and the cells were aspirated 
and dispensed back into culture flask in a subcultivation ratio 1:2 to 1:4. The frozen 
stocks of cells were stored with 95% culture medium and 5% D M S O under -80 
The cells were maintained between and passages for experiments. 
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3.2.2.2 Glucose Production Assay 
Glucose production assay were carried out according to the method published by 
Waltner-Law et a!., 2002 and Wang et al., 2000. 1.2 x 10^ cells were seeded in 
100mm dishes. After two days growth period, seeded cells were divided into three 
groups (with n=3 for each set of experiment): positive control, negative control and 
herbal water extracts treatment group. Then, the medium inside the dishes was 
removed and replaced by 3ml D M E M containing 500nM dexamethasone (DEX) and 
0.1 m M pCPT-cAMP. For negative control group only prepared medium was added; 
for positive control group, lOnM insulin was added together with prepared medium; 
and finally for herbal water extracts treatment group, different herbal extract 
concentrations (5, 1, 0.2mg/ml) were added together with prepared medium. The 
herbal extracts first need to dissolve into prepared medium followed sterilization and 
filtration of non-dissolved debris by 0.22iim filter (Millipore, Billerica, Mass, USA). i 
After incubating for five hours, the medium was removed and the dishes were 
washed with PBS for three times. Two milliliters of glucose production buffer 
(glucose-free D M E M without phenol red, 5 m M sodium pyruvate, 5 0 m M sodium 
lactate) was then added in each dish. After three more hours incubation, the 
concentration of glucose produced by the cells was measured with use of an 
enzymatic-spectrophotometric glucose oxidase/peroxidase method, in which 1ml 
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buffer was aspirated and added into 0.3ml glucose assay solution (BioSystems, 
Barcelona, Spain), and incubated at 3TC for ten minutes. Absorbance at O D 500nm 
was recorded. After that, dishes were washed with PBS, and the cells were lysed with 
5ml 0.5M N a O H for ten minutes. The lysate was neutralized with 5ml 0.5M HCl. 
The protein concentration of each dish was determined by bicinchoninic acid protein 
(BCA) assay (to be discussed in section 3.2.2.3). The amount of glucose produced by 
cells was normalized by their protein concentrations. Results were expressed as the 
percentage of glucose production of the negative control. 
For statistical analysis, Mann-Whitney tests were used for comparisons of 
glucose production in H4IIE cells between control group and each herbal extract 
treatment group. Statistical tests were two-sided, with a significant level of 0.05. 
3.2.2.3 Bicinchoninic Acid (BCA) Protein Assay 
Working assay reagent was freshly prepared by mixing B C A Reagent A (Bio-
Rad, Hercules, CA，USA) and Reagent B (4% CuS04-5H20) in a ratio of 49:1. Then, 
30|il of each sample and also bovine serum albumin (BSA) standard (0-10 mg/ml) 
were added into 96-well plate wells, after with 200|li1 working assay reagent. After 
incubation at 37°C for 30 minutes, O D 540mn was measured with Bio-Rad (Hercules, 
CA, USA) 3550 microplate reader. The sample protein concentration was determined by 
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the calibration curve of an albumin standard. 
3.2.3 Results 
Results of glucose production assay are shown in Fig. 3.2a and Fig. 3.2b. In Fig. 
3.2a, it showed that insulin, which acted as positive control, inhibited glucose 
production of H4IIE by 69% compared with that of control, and thus validated the 
model. 
Among all tested herbs, Cortex Phellodendri (5mg/ml), Rhizoma Copitidis 
(Img/ml and 5mg/ml) and Radix Pseudostellariae (5mg/ml) showed the most 
promising inhibitory effect on glucose production, which were 81.6%, 64.1%, and 
88.8% inhibition respectively. Some of the other herbs also had significant inhibitory 
effects on gluconeogenesis, while some of them were found to have a stimulatory 
effect on gluconeogenesis. ^ 
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Fig. 3.2 Effects of herbal water extract treatments on gluconeogenesis in H4IIE 
hepatoma cells. The effect of insulin on gluconeogenesis was shown in (a); and that 
of the herbal water extracts was shown in (b). Cells were incubated with different 
herbal water extracts, or with lOnM of insulin in medium with DEX/pCPT-cAMP, 
then glucose production buffer containing gluconeogenic precursors was added, 
followed by determination of glucose released into the glucose production buffer by 
glucose oxidase assay. The amount of glucose produced was normalized by cell 
protein. The glucose production values of the herbal extract treated group were 
expressed as the percentage of the untreated control group (which is 100%). Data are 
expressed as mean 土 S D (n =9). Significantly different from water control group: 
*p<0.05, **p<0.01, ***p<0.001. 
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3.3 Intestinal Glucose Absorption Studies 
3.3.1 Introduction 
Carbohydrates are our major energy source. Small intestine is the major organ in 
our body which absorbs carbohydrates from daily food intake (Sala-Rabanal et al., 
2004). There are many villi on the surface of intestine lumen to increase the surface 
area for nutrients absorption. Brush border membrane is found on the tips of the 
microvilli (on the surface of villi). The functional elements of the brush boarder 
membrane provide for the terminal digestion of carbohydrates and oligopeptides as 
well as their absorption of monosaccharides and amino acids (Schmitz et al., 1973). 
Brush border membrane vesicle (BBMV) was first successfully purified from brush 
border membrane of human small intestine in 1973 (Schmitz et al., 1973) and the 
purification method was further improved in 1978 by using Mg2+ precipitation 
method (Kessler et al., 1978). The final product has no D N A , no other metabolic , 
enzymes, but presented mainly Na+/D-glucose cotransporter 1 (SGLTl) (Kessler et 
al., 1978; Schmitz et al., 1973). Over 90% of B B M V have the right orientation, 
exterior side allocates with SGLTl and interior side (lumen) has no metabolic 
enzymes, hence solute being absorbed by transporters would not be metabolized and 
allowed for accumulation inside (Haase et al” 1978). The glucose uptake of B B M V 
is well-characterized, SGLTl is the transporter responsible for glucose absorption, 
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by transporting two Na+ with one D-glucose molecule in the expense of ATP 
(Semenza et al., 1984; Kessler et al., 1978). As a result, B B M V was commonly used 
as in vitro research subject of glucose absorption. 
For type 2 diabetic patients, the regulatory mechanisms of glucose homeostasis 
were defective due to insulin resistance and insulin deficiency: glucose disposal into 
peripheral tissues are defective, hepatic glycogen storage from glucose is lowered, 
1 
also gluconeogenesis rate is increased at the postprandial stage (Gerich, 1997). ！ 
I 
Western drugs such as acarbose and a-glucosidase inhibitor are used to control 
glucose absorption by competitively inhibiting the ability of a-amylase and the a-
glucosidase enzymes on the small intestinal brush border to break down 
oligosaccharides and disaccharides into monosaccharides (DeFronzo, 1999). In the 
present study, inhibitory effect of herbal hexane or dichloromethane extracts on 
glucose absorption through the small intestine was investigated. By inhibiting the “ 
glucose absorption, postprandial blood glucose level surge could be controlled. 
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3.3.2 Materia丨 and Methods 
3.3,2.1 Preparation of BBMV 
3.3.2.1.1 Chemicals 
Here is the list of chemicals used in this experiment: 
1. Purchased from Sigma (St. Louis, M O , USA): 
Potassium chloride (KCl), mannitol, 4-(2-hydroxyethyl)piperazine-1 -
� I 
'I 
ethanesulphonic acid (HEPES), tris(hydroxymethyl)aminomethane (Tris), f 
il I丨 
magnesium chloride (MgCb), magnesium sulphate (MgS04), sodium thiocyanate : 
I 
(； 
(NaSCN), sodium chloride (NaCl), phlorizin (phloretin 2'-glucoside, also known 
as phloridzin) and copper(II) sulphate pentahydrate (CUSO4.5H2O). 




B B M V was prepared by the Mg2+ precipitation method (Kessler et al, 1978; 
Schmitz et al, 1973). A N e w Zealand white rabbit was scarificed and the small 
intestine was freshly dissected from the pyloric sphincter to ileocaecal junction. 
Firstly, the dissected intestine was immersed in 200ml ice-cold 154mM KCl. 
Secondly, all the fat tissues and mesentery were removed clearly and the content of 
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intestine was gently squeezed out. Thirdly, the intestine was cut longitudinally and 
washed thoroughly with 154mM KCl. The cut intestine was placed onto paper towers 
and blotted dry, and then it was wrapped with aluminum foil and snap frozen in 
liquid nitrogen. The frozen intestine was stored at -80°C. 
To prepare B B M V , frozen small intestine was thawed in 200ml Buffer 1 (lOmM 
mannitol, 2 m M HEPES-Tris, pH 7.1) and was cut into small pieces, followed with 
� t 
mechanically vibrateion for one minute. The solution obtained was filtered under j 
11 
i 




300ml with Buffer 1. After that, 0.61g M g C b was added to precipitate nuclei, ：• 
I 
mitochondria, most of basolateral membranes and other cell debris. The solution was 
centrifuged at 4。C, 3800xg for 15 minutes. The pellet was discarded, and the 
supernatant was collected and further centrifuged at 4。C, 43000xg for 30 minutes. 
The supernatant was discarded, and the pellet was resuspended in Buffer 2 (lOOmM L 
mannitol, 0.1 m M MgSCU, 2 m M HEPES-Tris, pH 7.4). The solution was centrifuged 
at 4。C, 43000xg for 40 minutes and the pellet was resuspended in 1ml Buffer 3 
(300mM mannitol, l O m M HEPES-Tris, 0.1 m M MgS04, pH 7.4). The volume of 
pellet was doubled using Buffer 3. The solution was passed through a 25 gauge 
needle five times to form vesicles. The solution containing B B M V was then divided 
into 0.26ml aliquots and snaps frozen in liquid nitrogen. 
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3.3.2.2 Preparation of Herbal Extracts 
B B M V was used to study the effect of herbal extracts on intestinal glucose 
absorption. In this experiment, B B M V was incubated with radioactive glucose and 
herbal extract only. As the glucose concentration in the final B B M V mixture was 
only 0.067mM, so any glucose present in herbal extracts would affect the result by 
showing false positive. Hence, glucose inside herbs must be cleared by using an 
organic extraction method. However, many polar compounds were inevitably 
excluded by using this method. 
Each herb was sliced into small pieces, and the weight was recorded before 
extraction. 200ml absolute ethanol (100% EtOH) was added per 50mg herb, then 
refluxed for two hours. The extracted solution was collected and the herb was 
refluxed for two more hours with fresh 200ml absolute ethanol, and a second 
extracted solution was collected. The two extracted solutions were combined together. 
After that, the solution was filtered through filter paper, and collected in a pre-
weighed 250ml round bottom flask. The solvent inside the filtrate was evaporated 
using a rotary evaporator, and the dried content was weighed. 
The ethanolic extract was re-dissolved in 100ml distilled water and partitioned 
with 100ml hexane (Lab-Scan, Bangkok, Thailand). The hexane fraction was 
collected, and the water fraction was partitioned again with 100ml of fresh hexane. 
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Two hexane fractions were combined in a pre-weighed round bottom flask. The 
remaining water fraction was partitioned with 100ml dichloromethane (CH2CI2) 
(Lab-Scan, Bangkok, Thailand). Dichloromethane fraction was collected in a pre-
weighed round bottom flask, and the water fraction was partitioned once again with 
100ml of fresh dichloromethane. Again, two dichloromethane fractions were 
combined in the same flask. Anhydrous sodium sulphate (MERCK, Darmstadt, 
Germany) was added to absorb any remaining moisture in both hexane and 
dichloromethane extracts. The two solutions were filtered and the two extracts were 
dried using a rotary evaporator. The weights of two fractions were recorded. The 
dried fractions were stored in a desiccator. 
3,3.2.3 BBMV Glucose Uptake Assay 
A rapid filtration technique was used in this assay (Hopfer et al., 1973). A time 
profile of each batch of prepared B B M V was made before it was used in the 
experiment as a quality control measure; also by this method the optimal time point 
for B B M V glucose uptake in the assay could be found. The batch of B B M V was 
proven to be functional if glucose uptake increased sharply with time peaking at 
around 10-30 seconds, and decreased gradually until 120 seconds. 
Firstly, B B M V was thawed and resuspended in 0.44ml of Buffer 3. Then, 20|il 
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of diluted B B M V was mixed with 40)11 of radiolabelled glucose solution (10|iCi/ml 
D-[2-^H]-glucose, 0.1 m M D-glucose, lOOmM NaSCN, lOOmM mannitol, l O m M 
HEPES-Tris, pH 7.4). The reaction was stopped after specific incubation time (0, 10, 
20, 30, 40, 60 and 120 seconds) by adding 1ml ice-cold stop-wash buffer (200mM 
NaCl, l O m M HEPES-Tris, 250|xM phlorizin, pH 7.4), containing phlorizin as the 
SGLTl inhibitor (competitive inhibitor). The reaction mixture was rapidly filtered 
through a pre-wetted 0.45|im cellulose nitrate filter (Millipore, Billerica, Mass, USA) 
under vacuum. The filter was washed five times with 1ml stop-wash buffer to wash 
away the non-specifically bound radiolabelled glucose, and B B M V which absorbed 
radioactive D-glucose was retained on the filter. The filter was then placed inside a 
scintillation vial with 4ml OptiPhase HiSafe 2 scintillation fluid (PerkinElmer life 
sciences, Inc., Boston, M A , USA). Radioactivity was counted by scintillation counter 
I. 
for one minute. The value of 0 second, representing the non-specific binding of ^ 
glucose, was subtracted from all samples for the correction. 
The protein concentration of B B M V suspension was determined. One aliquot of 
frozen B B M V (0.26ml) was resuspended in 0.44ml of water. Various dilutions (10-
fold, 50-fold and 100-fold) were prepared, and the protein concentrations were 
determined by B C A assay (to be mentioned in section 3.3.2.4). Glucose uptake of 
B B M V was normalized with a standard curve using different concentrations of 
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B B M V protein, and expressed as pmol glucose uptake per m g protein. 
To screen the inhibitory effect of glucose absorption of each herbal extracts, the 
experiment was performed in the same way, but at fixed time points. Both hexane 
and dichloromethane herbal extracts were dissolved in 100% EtOH in a 
concentration of 20mg/ml. Then, 20|il of diluted B B M V was mixed with 10|il of 
0.4mM radioactive glucose solution (40|xCi/ml D-[2-^H]-glucose, 0.4mM glucose, 
4 0 0 m M NaSCN, 4 0 0 m M mannitol, 4 0 m M HEPES-Tris, pH 7.4) and 30|il of herbal 
extract (diluted to Img/ml by water, and the final EtOH concentration was equal to 
4%). A control group was also made by using 4 % v/v absolute EtOH in lieu of herbal 
extract, so as to compare with the effect of the herbal extracts. Glucose uptake was 
stopped after 20 seconds incubation (the optimum time of B B M V glucose uptake 
was investigated in the profile, i.e. 20 seconds) by adding 1ml of ice-cold stop-wash 
) 
buffer. The glucose uptake by B B M V was measured as described previously in this . 
section. 
For statistical analysis, Mann-Whitney tests were used for comparisons of 
glucose absorption of B B M V between the control group and each herbal extract 
treatment group. Statistical tests were two-sided, with a significant level of 0.05. 
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3.3.2.4 Bicinchoninic Acid (BCA) Protein Assay 
B C A protein assay was prepared as described in section 3.2.2.3. The Sample 
protein concentration was determined by the calibration curve of the albumin standard. It 
is used to normalize the radioactive count of glucose absorption. 
3.3.3 Results 
A typical glucose uptake profile of B B M V is shown in Fig. 3.3. The bell shape 
with a peak at 20 second showed it had the highest glucose penetration across the 
SGLTl at that time and the glucose absorption decreased to one-tenth of the peak 
value at 3600 seconds, which proved the batch of B B M V was capable for use 
(Kessler et al, 1978; Semenza et al, 1984). 
Results of B B M V glucose uptake assay were shown in Fig. 3.4. From the results 
of herbal dichloromethane extract treatment (Img/ml), Radix Glycyrrhizae, Radix . 
Ophiopogonis and Radix Trichosanthis showed the most potent and significant 
inhibitory effect on intestinal glucose absorption, with 82.8%, 93.1% and 81.2% 
inhibition respectively. And for hexane extract herbal treatments, Radix Glycyrrhizae, 
Radix Ophiopogonis and Radix Trichosanthis exerted the most potent significant 
inhibitory effect on intestinal glucose absorption, with 78.4%, 98.1% and 95.43% 
respectively. All herbal extracts showed sufficient inhibitory effect in suppressing 
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B B M V glucose absorption except Img/ml of dichloromethane extract of Semen 
Ziziphi Spinosae. None of the herbal extracts exerted stimulatory effects on 
absorption. 
r 
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Fig. 3.4 Effects of herbal organic extract treatments on intestinal glucose 
absorption of BBMV. B B M V were mixed with ^H-glucose and herbal 
dichloromethane or hexane extracts (1 mg/ml) at room temperature and the glucose 
uptake reaction was stopped at 20 seconds by the addition of stop-wash buffer. The 
amount of radioactive glucose influx was normalized by the vesicle protein 
concentration. The glucose absorption enhanced by herbal extracts was expressed in 
percentage absorption compared with control (100%). Data are expressed as mean 
士SD (n =9). Significantly different from 2% v/v EtOH control group: *p<0.05, 
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3.4 Fibroblast Glucose Uptake Studies 
3.4.1 Introduction 
Enhancing glucose uptake into peripheral tissue is one of the blood glucose 
homeostasis strategies. Cellular glucose uptake is facilitated by a family of glucose 
transporters (GLUT) (Bell et al., 1990; Macheda et al., 2005). Basal glucose uptake 
is mainly sustained by GLUTl, which is non-insulin dependent. G L U T l is mostly 
present in fibroblasts. The basal glucose uptake in these peripheral tissues is lower 
than normal (Kahn, 2000). Hence, improving glucose uptake in fibroblasts is 
beneficial to maintaining glucose homeostasis in type 2 diabetic patients. In the 
present study, human fibroblast cell line Hs68 was employed for investigation of the 
effect of herbal water extract on their enhancing effect in insulin independent basal 
glucose uptake into fibroblast. 
Hs68 is a human foreskin fibroblast cell line developed from an apparently ‘ 
normal newborn male (Corcoran and Stetler-Stevenson, 1995). It provides a model 
for non-insulin dependent glucose uptake study on GLUTl (Gherzi et al., 1992). 
Fibroblasts provide a convenient model for glucose transport study as it composes 
15% of an individual's total body weight, hence a reduction of the glucose uptake 
into skin cells could lead to increased glucose levels in the blood (Gherzi et al., 
1992). 
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2-deoxy-D-glucose (2-DOG), which is a glucose derivative, could not be 
metabolized by the cell, is used in glucose uptake study instead of glucose. It is 
because 2-deoxy-D-glucose undergoes phosphorylation inside the cells and cannot be 
further metabolized into the glycolytic intermediates (Navon et al., 1989). 
3.4.2 Material and Methods 
1. Purchased from Sigma (St. Louis, M O , USA): 2-deoxy-D-glucose (2-DOG) 
2. Purchased from Gibco B R L Life Technologies, Inc. (Carlsbad, CA, USA): 
Glucose-free D M E M 
3. Purchased from Amersham (Little Chalfont, UK): 2-Deoxy-D-[l-^H]-glucose (2-
D O G ) 
3.4.2.1 Cell Culture of Hs68 
The cell culture procedures for human skin fibroblasts Hs68 (ATCC, Manassas, 
VA, USA) were the same as that of H4IIE cultures (refer to section 3.2.2.1). In this 
study, Hs68 was maintained between and passages. 
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3.4.2.2 2-Deoxy-D-glucose Uptake Assay 
The assay was performed as described by Jarvill-Taylor et al (2001). Hs68 
fibroblasts were allowed to grow to a confluent state in 24-well plates. Hs68 cells 
were then glucose-starved by glucose-free D M E M for 1 hour. Cells were divided 
into a negative control group (glucose-free D M E M ) , and herbal treatment groups (10, 
1, 0.1 and O.Olmg/ml herbal water extracts dissolved in glucose-free D M E M , filtered 
with 0.22|im filter (Millipore, Billerica, Mass, USA)). Cells were incubated at 37°C 
for 30 minutes. The cells were then washed with PBS for three times to remove the 
herbal extracts. Three hundred microliters radiolabeled 2-DOG mixture (2|iCi/ml 2-
deoxy-D-[ 1 -^H]-glucose, 0.1 m M 2-DOG in glucose-free D M E M ) was added and 
incubated for 15 min at 3TC. Reactions were then stopped by adding 1 ml/well of 
ice-cold l O m M 2-DOG solution, and each well was washed twice more by the same 
ice-cold l O m M 2-DOG solution to remove any unbound radioactive glucose. A non-
specific binding control was performed in each experiment set, in which no treatment 
was applied and radioactive 2-DOG mixture was added after adding ice-cold 2-DOG 
into the wells. It was used to determine the non-specific binding of the radioactive 2-
D O G on the cell membrane surface. Then, lOOjil of 0.5M N a O H was added to lyse 
the cells, and equal amount of 0.5M HCl was then added to neutralize the cell lysate. 
Afterwards, 120|xl of the cell lysate was transferred into scintillation vials and 4ml of 
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OptiPhase HiSafe 2 scintillation fluid (PerkinElmer, Boston, M A , USA) was added 
for radioactivity counting by a liquid scintillation counter. Protein content of samples 
was determined by B C A assay (section 3.2.2.3). 
The radioactive count of glucose uptake was corrected by subtracting the mean 
of non-specific binding values, and then the amount of 2-DOG uptake was corrected 
by the protein amount. Results were expressed as the percentage of 2-DOG uptake 
compared with that of the negative control. 
For statistical analysis, two-sided Mann-Whitney tests were performed for 
comparisons of 2-DOG uptake between control and treatments, with a significant 
level of 0.05. 
3.4.2.3 Bicinchoninic Acid (BCA) Protein Assay 
B C A protein assay was carried out as described in section 3.2.2.3. The sample 
protein concentration was determined by the calibration curve of albumin standard. It is 
used to normalize the radioactive count of glucose uptake. 
3.4.3 Results 
The results in Fig. 3.5 showed that most of the lOmg/ml herbal extract gave 
significant stimulation on radio-labelled 2-deoxyglucose uptake into Hs68 fibroblasts 
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through GLUTl. Radix Codonopsis (lOmg/ml), Radix Paeoniae Alba (lOmg/ml) and 
Semen Ziziphi Spinosae (0.01 mg/ml) showed the most potent and significant 
enhancing effect on peripheral tissue glucose uptake, which increased the uptake by 
114.1%, 133.9% and 220.4% respectively. For Radix Codonopsis it showed a dose 
dependent effect, while that of Semen Ziziphi Spinosae has an opposite effect (i.e. 
the higher of the dose, the smaller the effect). It might be due to toxicity of the herbal 
extract, hence the higher the dosage used, the more cells died and thus led to a 
decrease in 2-DOG uptake. 
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Fig. 3.5 Effects of herbal water extract treatments on glucose uptake of Hs68 
human skin fibroblasts. Hs68 fibroblasts were incubated for 30min with different 
herbal water extracts, followed by the addition of 2-deoxy-D-[ HJglucose for glucose 
uptake assays. The uptake reaction was stopped at 15min incubation by the addition 
of an ice-cold 2-DOG solution 1 O m M . The amount of radioactive glucose influx was 
normalized by cell protein concentrations. The glucose uptake values of the herbal 
water extract treated group were expressed as the percentage of the treated compared 
to that of untreated control group (100%). Data are expressed as mean 士SD (n =9). 
Asterisks were used to indicate significantly different results of treated groups 
compared with the water control group: *p<0.05, **p<0.01. 
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3.5 Adipocyte Glucose Uptake Studies 
3.5.1 Introduction 
Both skeletal muscle and adipose tissue are main tissues that response to blood 
glucose homeostasis (Li and Kandror, 2005; Rudich et aL, 2003). They express non-
insulin dependent G L U T l and insulin responsive G L U T 4 on their cell surface. 
G L U T l is responsible for the basal glucose transport while G L U T 4 is responsible for 
the insulin-stimulated glucose transport in the adipocytes (Harrison et al., 1992). 
G L U T 4 is originally located inside the cytoplasm of adipocytes. In the basal state, 
most of the G L U T 4 is sequestered in vesicular membranes inside the adipocyte. 
Upon insulin stimulation, G L U T 4 translocation is triggered, and translocates on cell 
membrane, resulting in an increase in GLUT4 content on the cell surface which 
enhance glucose uptake (Hashiramoto and James, 2000; Walton et al., 2004). 
Once blood glucose level is high, insulin is released from the pancreatic islet, . 
and glucose uptake through GLUT4 into skeletal muscle and adipocyte is stimulated. 
This could lower the blood glucose level and maintains it at a steady level (Proietto 
et al., 1983). At an insulin resistance state of diabetic patients, glucose uptake into 
peripheral tissues is suppressed as insulin sensitivity of these cells is defective 
(Summers et al., 1999). Moreover, the basal glucose uptake of the adipose tissue is 
lower than that of the normal state (Stolic et al., 2002). Western oral medication 
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thiazolidinedione can target insulin-responsive tissues to enhance their glucose 
transport and improve their insulin sensitivity (Martens et al., 2002). Hence, 
improving the glucose uptake in skeletal muscle and adipocytes is beneficial to 
maintain glucose homeostasis in type 2 diabetic patients. 
Adipocytes were used as the model in this experiment for peripheral tissue 
regulating insulin-stimulated glucose homeostasis. The effects of the herbal water 
extracts on glucose uptake into these cells were studied. Mouse adipocyte 3T3-L1, 
which is a continuous substrain of 3T3 cell line, is an embryonic fibroblast cell line 
isolated from Swiss albino mouse (Green and Meuth, 1974). It can be induced into 
adipocytes from a pre-adipocyte state or from a rapidly dividing to a confluent and 
contact inhibited state by stimulation with 3-isobutyl-1 -methylxanthine (IBMX), 
dexamethasone (DEX) and insulin (Green and Meuth, 1974). The morphology of 
full differentiated adipocytes is different from that of the fibroblasts and shows 
intracellular lipid accumulation (Wu et al., 1998). 3T3-L1 adipocytes can perform 
insulin responsive glucose uptake by activation of insulin (Fong et al., 1991). 
Glucose uptake assay was carried out similar to section 3.4.2.2 by means of 2-deoxy-
D-gluose (2-DOG). 
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3.5.2 Material and Methods 
1. Purchased from Sigma (St. Louis, M O , USA): Dexamethasone, 3-isobutyl-l-
methylxanthine (IBMX), insulin, paraformaldehyde and 2-deoxy-D-glucose (2-
D O G ) 
2. Purchased from Gibco B R L Life Technologies, Inc. (Carlsbad, CA, USA): 
Glucose-free D M E M 
3. Purchased from Amersham (Little Chalfont, UK): 2-Deoxy-D-[ 1 -^H]-glucose 
3.5.2.1 Cell Culture of 3T3-L1 
The cell culture procedures for mouse fibroblast 3T3-L1 (ATCC, Manassas, VA, 
USA) were the as same as the culture method of H4IIE (refer to section 3.2.2.1). In 
this study, 3T3-L1 cells were maintained between and passages. 
3.5.2.2 Differentiation of 3T3-L1 
3T3-LI fibroblast cells were chemically induced into differentiated adipocytes 
before glucose uptake assay was carried out. Cells were seeded on the 24-well plates 
and maintained until after a confluent state for two days (Day 0). The medium was 
switched to IBMX-DEX-INS cocktail medium (0.5mM IBMX, 0.5|^M 
dexamethasone and 5jig/ml insulin in complete D M E M , freshly prepared) at day 0. 
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On day 3, the IBMX-DEX-INS cocktail medium was removed and changed into the 
complete medium supplemented with 5|ig/ml insulin. Two days later (day 5), the 
cells were maintained in normal complete medium ( D M E M with 10% FBS, 
100|ig/ml streptomycin and lOOunit/ml penicillin) and fed every other day. The cells 
were ready for use between day 9 and day 12. 
Oil red O staining was applied to differentiated 3T3-L1 cells to detect the 
amount of lipid accumulation (i.e. to confirm the induction level of 3T3-L1). The 
cells were fixed with 2 % paraformaldehyde (Sigma, St. Louis, M O , USA). Oil red O 
solution was prepared by mixing oil red O saturation isopropanol solution with 
distilled water in a ratio of three to two, and then allowed to stand in room 
temperature for 10 minutes, filtered immediately before used. This freshly prepared 
oil red O solution was added to the cells in 24-well plates, and allowed to stand in 
room temperature for 10 to 15 minutes. The solution was then washed away with , 
PBS and the cells were observed under a light microscope. The lipid accumulation 
density in the differentiated cells should be around 90%. 
3.5.2.3 2-Deoxy-D-glucose Uptake Assay 
This assay was performed similar to the assay described in section 3.4.2.2. 
Differentiated 3T3-L1 cells were allowed to grow into a confluent state in 6-well 
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plates. 3T3-L1 cells were then serum-starved by glucose-free D M E M for 1 hour. 
Cells were divided into 2 sets (insulin-treated group and non-insulin-treated group), 
and each set contained a negative control group (glucose-free D M E M ) , and herbal 
treatment groups (10, 1, 0.1 and 0.01 mg/ml herbal water extracts dissolved in 
glucose-free D M E M , filtered with 0.22|im filter (Millipore, Billerica, Mass, USA)). 
Different treatments were added to the cells and the cells were incubated at 37。C for 
t\ 
t：' 
30 minutes. The cells were then washed with PBS for two times to remove the herbal ; 
extracts. Afterwards either set of the cells (insulin treated group) were incubated with 
lOnM insulin at 37°C for a further 30 minutes. Three hundred microliters 
radiolabeled 2-DOG mixture (2jiCi/ml 2-deoxy-D-[ 1 -^H]-glucose, 0.1 m M 2-DOG 
in glucose-free D M E M ) was added and incubated for 15 minutes at 37°C. Reactions 
were then stopped by adding 1 ml/well of ice-cold l O m M 2-DOG solution, and each 
well was washed twice more by the same ice-cold lOmM 2-DOG solution to remove ,‘ 
any unbound radioactive glucose. Non-specific binding was performed in each 
experiment set, in which no treatment was applied and radioactive 2-DOG mixture 
was added after adding ice-cold 2-DOG into the wells. It was used to determine the 
non-specific binding of the radioactive 2-DOG on the cell membrane surface. Then, 
200|il of 0.5M N a O H was added to lyse the cells, and equal amounts of 0.5M HCl 
was then added to neutralize the cell lysate. Afterwards, 300|il of the cell lysate was 
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transferred to scintillation vials and 4ml of OptiPhase HiSafe 2 scintillation fluid 
(PerkinElmer, Boston, M A , USA) was added for radioactivity counting by a liquid 
scintillation counter. The protein content of samples was determined by B C A assay 
(section 3.2.2.3). 
The radioactive count of glucose uptake was corrected by subtracting the mean 
of non-specific binding values, and then the amount of 2-DOG uptake was corrected 
by protein amount. Results were expressed as the percentage of 2-DOG uptake 
compared with that of the negative control. 
For statistical analysis, two-sided Mann-Whitney tests were performed for 
comparisons of 2-DOG uptake between control and treatments, also insulin-treated 
and non-insulin treated, with a significant level of 0.05. 
3.5.2.4 Bicinchoninic Acid (BCA) Protein Assay 
B C A protein assay was performed as described in section 3.2.2.3. The sample 
protein concentration was determined by the calibration curve of albumin standard. It 
was used to normalize the radioactive count of glucose uptake. 
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3.5.3 Results 
In Fig. 3.6(a), it showed that the radiolabeled 2-DOG uptake was enhanced by 
insulin (act as positive control), therefore validated the model. The results were 
shown in Fig. 3.6(b). The insulin treatment group had inhibitory effect on radio-
labelled 2-deoxyglucose uptake rather than stimulatory effect (except 10 mg/ml of 
Cortex Phellodendri) comparing that of non-insulin treatment group with the same 
concentration. Only Cortex Phellodendri (lOmg/ml) exerted herb-insulin interaction 
in glucose uptake while other herbal extracts did not; and our results suggest that 
Cortex Phellodendri (lOmg/ml) could improve the insulin sensitivity of the cells. 
From the results, none of the herbal treatment exhibited a significant increase in 
glucose uptake into 3T3-L1 adipocytes. On the contrary, all tested concentration of 
i I 
Rhizoma Coptidis with insulin, Cortex Phellodendri with insulin (0.01 mg/ml and 
1 mg/ml), Radix Ophiopogonis with insulin (1 mg/ml and 1 Omg/ml) and Radix 
Ophiopogonis without insulin (1 mg/ml and 1 Omg/ml) treatment groups significantly 
inhibited glucose uptake, which were unfavourable effects. 
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Fig.3.6 Effects of herbal water extract treatments on glucose uptake of 3T3-L1 
adipocytes. 3T3-L1 adipocytes were incubated for 30mins with different herbal 
water extracts, and then incubated for another 30mins with lOOmM insulin (for with 
insulin treatment groups). Then 2-deoxy-D-[^H]glucose was added for glucose 
uptake assays. The uptake reaction was stopped at 15min incubation by the addition 
of an ice-cold 2-DOG solution lOmM. The amount of radioactive glucose influx was 
normalized by cell protein concentrations. The glucose uptake values of the herbal 
water extract treated group were expressed as the percentage of the treated compared 
to that of untreated control group (100%). Data are expressed as mean 士SD (n =9). 
Asteristo were used to indicate the significantly different results between each 
treatment group from water control group: *p<0.05, **p<0.01. 
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3.6 Glucose Transporter Type 4 (GLUT4) Expression Studies 
3.6.1 Introduction 
In type 2 diabetes, one of the main pathophysiologic defects is insulin resistance. 
In adipocytes, the decreased insulin sensitivity is due to a decreased expression of 
G L U T 4 (Minokoshi et al., 2003; Shepherd and Kahn, 1999). Both protein and 
m R N A levels of G L U T 4 are decreased in adipocytes under an insulin resistance state, 
resulting in a change of glucose homeostasis (Minokoshi et al., 2003). 
3.6.2 Materia丨 and Methods 
3.6.2.1 Cell Culture of 3T3-L1 
The cell culture procedures for mouse fibroblasts 3T3-L1 (ATCC, Manassas, VA, 
I 
USA) were the same as that of the culture method of H4IIE (refer to section 3.2.2.1). 
In this study, 3T3-L1 cells were maintained between and passages. 
3.6.2.2 Differentiation of 3T3-L1 
3T3-LI fibroblast cells were chemically induced into differentiated adipocytes 
before expression assay was carried out. The method was the same as that of 3T3-L1 
adipocyte glucose uptake assay (refer to section 3.5.2.2). 
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3.6.2.3 GLUT4 Expression Assay 
Differentiated 3T3-L1 cells were allowed to grow into a confluent state in 6-well 
plates. 3T3-L1 cells then were serum-starved by glucose-free D M E M for 1 hour. 
Cells were divided into 2 sets (insulin-treated group and non-insulin-treated group), 
and each set contained a negative control group (glucose-free D M E M ) , and herbal 
treatment groups (10，1, 0.1 and O.Olmg/ml herbal water extracts dissolved in 
glucose-free D M E M , filtered with 0.22|ini filter (Millipore, Billerica, Mass, USA)). : 
Different treatments were added to the cells and the cells were incubated at 37°C for 
30 minutes. The cells were then washed with PBS for two times to remove the 
treatments. Afterwards insulin treated group were incubated with 1 OnM insulin, and 
non-insulin treated group were incubated with glucose-free medium. Both treatment 
I 
groups were incubated at 37°C for 30 minutes more. 
3.6.2.4 Preparation of RNA 
After treatment with different concentrations of herbal water extracts, R N A was 
purified from cells using TRIzol reagent (Invitrogen, Carlsbad, CA). Firstly, the 
medium from each well was removed, and 1ml TRIzol reagent was added into each 
well, and cells were incubated at room temperature for 5 minutes. The cell lysates 
were then pipetted into 1.5ml centrifuge tubes, 0.2ml of chloroform was added into 
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each tube and vigorously shaken for 15 minutes. Then, the tubes were centrifuged at 
14000rpm for 20 minutes at The upper colorless layer of the content (0.4ml) in 
the tubes was carefully removed to a clean centrifuge tube without disturbing the 
lower layer, and 0.4ml isopropanol was added to each tube and mixed well. After 
that, the tubes were centrifuged at 14000rpm for 20 minutes at 4°C. The supernatant 
was removed, and the white pellet was rinsed with cold 75% EtOH and air dried 
� 
briefly. Forty microliters of DEPC-treated sterile distilled water (DEPC-H2O) was : 
added to each tube to dissolve the pellets. R N A was quantitated by U V absorbance at 
I 
260nm; in all cases the ratio of the U V absorbance at 260nm to that at 280 nm was 
greater than 1.5. Five micrograms of extracted R N A were used for first-strand c D N A 
synthesis. 
3.6.2.5 RT-PCR 
Five to ten micrograms of R N A was added to 2ul oligonucleotide (lOpmol) and 
the final volume was adjusted to 37|il by DEPC-treated water. The reaction mixture 
was incubated at 65°C for 5 minutes and chilled on ice for 3 minutes. Reverse 
transcription was then performed at 42 for 1 hour with First-Strand Master Mix 
(5|il dNTP (lOmM), 5|il lOX buffer, l|al RNase inhibitor and l|il PowerScript™ 
Reverse Transcriptase). The mixture was heated at 90®C for 5 minutes to inactivate 
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reverse transcriptase, lul RNase H was added to the first-strand reaction product and 
incubated at ?>TC for 20 minutes to remove unused RNA. 
3.6.2.6 PGR Analysis on GLUT4 Expression 
For best results, the PCR cycling parameters were optimized. Choosing the 
optimal number of P C R cycles ensures that the double-stranded c D N A would remain 
I 
in the exponential phase of amplification. Over-cycling of PCR reaction would lower ， 
the quality of c D N A template for subtraction while under-cycling would lower the 
yield of PCR product. The optimal number of PCR cycle was one cycle before 
reaching the plateau. 2 sets of PCR reaction were performed with first-strand c D N A 
product (5|il G L U T 4 study group and 10|il for control group), l|il of primer mix 
(lOmM) (Forward primer sequence: 5, T G A A C A A T C T G A A C G C A C C G A 3'; 
Reverse primer sequence: 5' A G G A G A G C A G G G A G T A C T G T G A 3') and 19.5^1 of … 
PCR Master Mix including 2\i\ of lOX PCR buffer, 0.5|il of magnesium chloride 
(MgCh), l|il of dNTP (lOmM) and l|il of Taq polymerase, the final volume was 
adjusted to 20|il by distilled water. The reaction mixture was then subjected to 94°C 
denaturation for 5 minutes, followed by 30 cycles of amplification (94°C, 1 
minSO sec; 65°C, IminSO sec; 72。C，IminSOsec) and 72。C termination for 10 
minutes. 10|il of each PCR product was then analyzed on a 1.0% TAE 
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agarose/ethidium bromide (EtBr) gel with a fixed voltage at lOOV. After gel 
electrophoresis, the image was deteced under U V light and the band intensity was 
analyzed using a densitometer. The expression level of G L U T 4 was normalized by 
the expression level of the housekeeping gene G A P D H . 
For statistical analysis, student t-tests were performed for comparisons of 
between control and treatments, as well as those between control, insulin-treated and 
� 
non-insulin treated, with a significant level of 0.05. I 
i 
3.6.2.7 Real-time PGR 
Real-time PCR was developed because it can investigate the quantitated 
differences in m R N A expression, and is particularly valuable when the amounts of ； 
[ 
R N A are low, since the fact that PCR involves an amplification step. PCR is the most 
Hn' 
sensitive method and can discriminate closely related mRNAs. But using 
conventional PCR method, it is difficult to obtain a truly quantitative result due to the 
limited sensitivity of ethidium bromide. In contrast to regular reverse transcriptase-
PCR (RT-PCR) and analysis by agarose gels, real-time PCR gives a more 
quantitative result. An additional advantage of real-time PCR is the relative ease and 
convenience of use compared to some older methods. 
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The following paragraphs describe the experiment procedures. Total cellular 
R N A was extracted by TRIzol reagent and single-strand oligo-dT-primed c D N A was 
synthesized as described in section 3.6.2.4 and Real-time P G R was used to quantify 
G L U T 4 m R N A expression. 
The quantification was performed with the use of gene-specific primers, S Y B R 
Green Universal P G R Mix and an ABI Real-time P G R 7700 machine (Applied 
Biosystems) starting with first-strand cDNAs. The quantity of GLUT4 gene in each 了 
sample was normalized by the corresponding G A P D H expression levels. The primer 
1 
sequences for G A P D H amplification were 5 ‘ - A C C A C A G T C C A T G C C A T C A C - 3 ‘ 
(forward primer) and 5'-TCCACCACCCTGTTGCTGTA-3' (reverse primer). And 
the primer sequences for G L U T 4 amplification were 5'-
i 
A G A G C T A C A A T G C A A C G T G G C T - 3 ‘ (forward primer) and 5'-
A G G A G A G C A G G G A G T A C T G T G A - 3 ‘ (reverse primer). The reaction mixture was …I 
then subjected to PGR temperature profile of 50°C, 2min; 95°C, lOmin; 95°C, 
15sec; 60°C, Imin. Each sample was run in triplicate and the mean Ct value was 
used to calculate m R N A levels. The fold of change of m R N A level of each sample 
compared with control was calculated based on the method (Livak and 
Schmittgen, 2001). 
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For statistical analysis, student t-tests were performed for comparisons between 
control and treatments, as well as those between control, insulin-treated and non-
insulin treated, with a significant level of 0.05. 
3.6.3 Results 
Fig. 3.7 shows the gel electrophoresis of PGR products of the G L U T 4 gene and 
housekeeping G A P D H gene. Fig. 3.8 shows the band intensity of the D N A by gel ； 
electrophoresis. The band intensity was measured and expressed the percentage of 
GLUT4/GAPDH. The smaller the percentage, the higher is the G L U T 4 gene 
expression inside 3T3-L1 adipocytes after different herbal treatments. 
There was no significant increase in GLUT4 gene expression after 30 minutes 
herbal water extract treatment from RT-PCR. 
The results were further confirmed by quantitative real-time RT-PCR method. 
Results in Fig. 3.9 showed that none of the herbal treatment group gave a significant 
increase in the level of GLUT4 gene expression relative to that of G A P D H gene, 
which illustrated that there was no increase in the level of GLUT4 gene after 30 
minutes incubation with different herbal treatments. 
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CTL INS HB0.1 HB1 MD0.1 MD1 
GLUT4 
G A P D H 
CTL INS HL0.1 HL1 
GLUT4 ^ ^ • • • • • • l 
GAPDH 
Fig. 3.7 The representative RT-PCR of GLUT4 expression. 3T3-L1 adipocytes 
were incubated for 30min with different herbal water extracts, then another 30min \ 
with lOOmM insulin (for with insulin treatment groups).The total R N A was extracted 
from herbal water extract treated 3T3-L1 adipocytes and reverse transcribed, the 
product was amplified by PCR and then separated by agarose gel electrophoresis and . 
detected with ethidium bromide staining. The gene expression of GLUT4 was 
compared with that of housekeeping gene G A P D H (n=3). 
H B 0.1 = Cortex Phellodendri (0.1 mg/ml) H L 0.1= Rhizoma Coptidis (0.1 mg/ml) 
H B 1 = Cortex Phellodendri (1 mg/ml) H L 1= Rhizoma Coptidis (1 mg/ml) 
M D 0.1= Radix Ophiopogonis (0.1 mg/ml) 
M D 1 = Radix Ophiopogonis (1 mg/ml) 
I 
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Fig. 3.8 GLUT4 gene expression in 3T3-L1 adipocytes. Percentage ratio of 
G L U T 4 m R N A relative to G A P D H m R N A was calculated. The results were 、 
compared with control group without any treatment (100%). Data was expressed as 
mean 士SD (n=3). There is no significant increase in gene expression among all 
treatment groups. 
j 
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1 8 � • 0.01 mg/ml 
. c j • 0.1 mg/ml 
1 力 T • 1 mg/ml 
^ • 10 mg/ml 
0 1.4 T T y  
mm : 
Control Insulin Cortex Radix Rhizoma Coptidis ：丨: 
Phellodendri Ophiopogonis 丨 
Fig. 3.9 GLUT4 gene expression in 3T3-L1 adipocytes investigated with real-
time PCR. 3T3-L1 adipocytes were incubated for 30min with different herbal water 
extracts, then another 30min with lOOmM insulin (for those with insulin treatment 
groups). Then total R N A was extracted and GLUT4 gene expression was 
investigated by real-time PCR method. The results were compared with that of the 
control group without any treatment (100%). Data was expressed as mean 土SD (n=3). 
There is no significant increase in gene expression among all treatment groups. 
i i 
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3.7 Discussion 
3.7.1 Discussion of Hepatic Gluconeogenesis Studies 
Among all tested herbs, Cortex Phellodendri (5mg/ml), Rhizoma Copitidis 
(1 mg/ml and 5mg/ml) and Radix Pseudostellaria (5mg/ml) showed the most 
promising inhibitory effect on glucose production. No cell death was observed after 
drug treatment at 5mg/ml, which is considered as a high dosage. 
J 
Since this assay was to investigate the glucose production effect, any glucose ! 
,1, 
present in the herbal water extract would give false positive results. Moreover, 
( 
feedback inhibition of glucose production by glucose itself also may have a chance 
of leading into false positive results. But in H4IIE hepatic glucose production assays, 
the cells that treated with herbal water extracts was washed thoroughly by PBS 
I 
solution, before glucose-free glucose production buffer was added, so glucose in the 
！ 
herbal extract was being washed away and would not exert any effect on the assay. -
For further confirmation of the inhibitory effect of the potent herbs, PEPCK 
activity could be studied which measure the consumption of N A D H inside the H4IIE 
cells (Emoto et al., 1993; Wiese et al., 1991). Studies on the gene expression of 
gluconeogenic enzymes could also be conducted (Waltner-Law et al., 2002; Wang et 
al., 2000). 
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3.7.2 Discussion of Intestinal Glucose Absorption Studies 
In the B B M V intestinal glucose uptake assay, due to the very small final glucose 
concentration in the reaction mixture, which was only 0.067mM, any extra glucose 
present inside herbal extract would reduce the absorption of radiolabeled glucose and 
result in false positive results. But there is no effective method nowadays used to remove 
glucose in herbs. Hence, organic extracts of each herb were used instead of water 
extracts, as glucose could dissolve in water but not in non-polar solvent (the extraction I 
I 
method was discussed previously). In this assay, dichloromethane and hexane extract of 
each herb was investigated. ‘ 
The concentration of each treatment used was 1 mg/ml, as the herbal extract only 
dissolved in absolute ethanol, but high ethanol content would affect the result of glucose i 
I i I 
absorption of B B M V , so the concentration of herbal extract chosen should depend on the ！ 
！： 
final ethanol concentration inside the reaction mixture. Upon several trials (data not 
I 
shown), 1 mg/ml of herbal extract with a final ethanol concentration of 2% v/v was most 
suitable and acceptable. There was no significant difference between water and 2% 
ethanol as the solvent used in the reaction mixtures. 
Among all tested herbs, dichloromethane extracts of Radix Glycyrrhizae, Radix 
Ophiopogonis and Radix Trichosanthis showed the most potent and significant 
inhibitory effect of intestinal glucose absorption; while hexane extracts of Radix 
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Glycyrrhizae, Radix Ophiopogonis and Radix Trichosanthis exerted the most potent and 
significant inhibitory effect of intestinal glucose absorption. It suggests that they might 
contain some potent components on inhibiting SGLTl in the small intestine. 
It is deduced that the herbal extract affect the glucose absorption though SGLTl. 
Since B B M V is a model without any enzyme or ribosomes (Kessler et al., 1978; 
Schmitz et al, 1973)，further study of the mechanism of how herbal extracts inhibit the 
B B M V glucose absorption, such as a-glucosidases activity, is impossible (Kim et al., ; 
I 
2004c; Choi et a/., 2000). 
I 
3.7.3 Discussion of Fibroblast Glucose Uptake Studies 
The results showed that most of the herbal extracts (lOmg/ml) gave significant 
stimulation on radiolabelled 2-deoxyglucose uptake into Hs68 fibroblasts through 
GLUTl. Radix Codonopsis (lOmg/ml)，Radix Paeoniae Alba (lOmg/ml) and Semen 
Ziziphi Spinosae (O.Olmg/ml) showed most potent significant enhancing effect on 
peripheral tissue glucose uptake. In such a high concentration used, cytotoxicity needs to 
be considered. For Cortex Phellodendri and Rhizoma Coptidis treatment groups, cell 
death was observed in lOmg/ml, and led to a decrease in radiolabeled 2-DOG uptake 
(inhibitory effect showed in the results section). Moreover, as the concentration 
increased from O.Olmg/ml to Img/ml, the level of stimulatory effects of Cortex 
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Phellodendri and Rhizoma Coptidis on radiolabeled 2-DOG decreased, which illustrated 
the cytotoxicity effects of these two herbs when use in high dosages. 
Although skin fibroblast is not a major insulin responsive tissue, it is believed that 
the stimulation in the basal glucose uptake through G L U T l in insulin non-responsive 
tissues can also lower the blood glucose level (Gherzi et al, 1992). 
In this assay, as the incubation time of the herbal extracts was only 30 minutes, 
which was not likely to be triggered by increasing the expression level of GLUTl 
m R N A , but by G L U T l transloaction (Bosch et al., 2004; Powell et al., 1999), and it was 
necessary to be studied further. 
3.7.4 Discussion of Adipocyte Glucose Uptake Studies 
3T3-L1 adipocytes were greatly expressed with G L U T 4 which is responsible for 
insulin sensitive glucose uptake. The three herbs chosen from the previous in vitro 
• J 
screening with most potent anti-diabetic effects were carried out this assay. In this cell 
model, 1 OnM of insulin was added during the experiment to mimic the type 2 diabetes 
condition，and for studying the improvement effect of herbal extract on insulin 
sensitivity (Fukuen et al.’ 2005; Powell et al, 1999). Moreover, the herb-insulin 
interaction could be studied by the insulin-stimulated glucose uptake in the 3T3-L1 
adipocytes (Kamei et al., 2002; Nugent et al.’ 2001). 
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From the results, the radiolabeled 2-DOG uptake of insulin treated positive 
control group was higher than that of non-insulin treated negative control group. This 
proved that insulin had the stimulatory effect on glucose uptake of adipocytes. 
Cortex Phellodendri (lOmg/ml) exerted the interaction with insulin to enhance the 
glucose uptake into adipocytes, and showed to have improvement in insulin 
sensitivity in the cells. On the other hand, for the other herbal treatment groups, they 
suppressed the glucose uptake. 
The enhancing effect of such glucose uptake may be achieved by glucose 
transporters. In the 3T3-L1 adipocytes, GLUTl and GLUT4 are expressed. In the 
next section, the gene expression of GLUT4 upon stimulation of herbal water 
extracts and its relationship on glucose uptake will be discussed. ！ 
I 
In future studies, GLUT4-GFP (green fluorescence protein) can be used to study 
.I 
the glucose uptake mechanism through GLUT4 transloaction after herbal extract -
treatment (Powell et al., 1999). The herbal extracts may possess insulin-like effects 
on the 3T3-L1 adipocytes and stimulate the translocation of the GLUT4 proteins 
from the intracellular vesicles to the plasma membrane (Harrison et al., 1992). 
GLUTl also has translocation but to a smaller extent (Calderhead et al., 1990), and 
this effect has been demonstrated in Hs68 fibroblast glucose uptake study described 
in section 3.4. 
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3.7.5 Discussion of Glucose Transporter Type 4 (GLUT4) Expression 
Studies 
Insulin-stimulated glucose uptake in adipocytes is highly correlated with the 
expression level of GLUT4, and altered expression of G L U T 4 may play a role in the 
insulin resistance of type 2 diabetes (Shepherd and Kahn, 1999). Because of this, it is 
interesting to identify whether traditional Chinese herbs could affect the G L U T 4 
ir 
>/ i| 
regulations in adipocytes with insulin-like effect (Nugent et al., 2001). 
As there was no significant increase in G L U T 4 gene expression after 30 minutes 
herbal water extract treatment from RT-PCR and also real-time RT-PCR, that 
illustrated that there was no increase in the level of GLUT4 gene after 30 minutes 
i 
incubation with different herbal treatments. | 
I 
I 
This disappointing result might be due to insufficient herbal treatment 
incubation time, as the translational activity of glucose transporters usually need to 
take more than two hours (McGowan et al., 1995). Hence, we can conclude that the 
3T3-LI adipocytes glucose uptake assay was not affected by GLUT4 gene expression 
within 30 minutes. 
According to the results, hypothesis could be made that the glucose uptake in 
was due to an instant stimulation of GLUT4 uptake ability or other glucose uptake 
mechanisms. 
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To further investigate, longer incubation time of herbal extracts on the cells is 
needed for G L U T 4 gene translation. 
3.7.6 Conclusion 
The results of in vitro studies were summarized in Table 3.1. For B B M V glucose 
uptake assay, H4IIE hepatic gluconeogenesis assay, inhibitory effects were desirable 
for anti-diabetic agents; while for the Hs68 fibroblast glucose uptake and 3T3-L1 : 
adipocyte glucose uptake assays, stimulatory effects were desirable. 
Among 14 herbs tested, three herbs were selected out for further studies in 
diabetic animal model to confirm their potent anti-diabetic effects. Cortex 
I I 
Phellodendri，which has excellent inhibition in hepatic glucose production and 丨 
I 
• i 
desirable effect on intestinal glucose absorption and fibroblast/adipocyte glucose 
uptake, was chosen. Rhizoma Corptidis, which showed all positive effect in anti- 」 
diabetic with lower dosage then other herbs with positive result, was suitable for 
further investigation. Finally for Radix Ophiopogonis, although it had negative result 
in ability of inhibiting gluconeogenesis, its strong inhibitory effect on intestinal 
glucose absorption was desirable for further study in animal model. 
The advantage of using in vitro models compared with in vivo models and other 
clinical studies for pharmacological investigation that they are more convenient to 
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tackle with, they give fast response and hence faster to have results and allow the 
possible way to conduct large scale experiments. It also allows specific 
pharmacological mechanistic studies to be made, and there are no need to use so 
many animal, and thus easier for ethnical approval. 
The disadvantages of using in vitro assays are: First, the results obtained only 
represent the effect on specific types of cells, while any effect on animals or on 
humans is still not yet known, hence the results should be further confirmed by in 
vivo and clinical studies; second, cells chosen to carry out experiments from other 
species sometimes may not be human cells, the positive results using cell types could 
not represent the actual effect inside humans; third, since one in vitro study could 
！ 
only focus one specific mechanism, it could not cover other possible j 
j 
pharmacological mechanisms, hence more in vitro models are required. 
As restoring insulin secretion in pancreatic p-cells can be one of the modes of 」 
action in controlling blood glucose level of type 2 diabetic patients. In future studies, 
insulin-secreting cell lines, such as the hamster HIT-T15 p-cells cell line and RIN-
m5f can be used to study the enhancing effect on insulin secretion by traditional 
Chinese herbs (Noor et al., 1989) 
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Chinese Herbs H4IIE hs68 3T3-L1  
(CH2CI2) (Hexane)  
Radix Paeoniae Alba 
+27.51 -31.42 -78.38 +114.11 . 
(0.2) *** *** (10) 
Semen Platycladi +90 28 
-17.30 -78.18 -57.95 , 
(5) *** *** v^ l^/ 
Radix Codonopsis ^ ^ ^ +133.86 
+O.UU -J 1.00 -Jj.lo 门… , 
⑴ *** *** 
Herba Lophatheri 
^ +7.98 -45.06 -54.01 -3.02 , 
(5) *** *** (0.1) 
Radix Glycyrrhizae � ^ � � ”八 ” � � 
^ -27.96 -82.76 -77.50 +41.22 丨 
(5) *** *** (1) 
Radix Puerariae �八 , , 
+29.46 -44.59 -35.57 +5.05 . 
(5) *** *** (1) 
Ramulus Cinnamorni^^^；；；^ ^ ^ “ 
(1) *** *** (0.01) 
Cortex Phel lodendri -81.55 , … … � +58.19 丄””，丄 r � • 
-23.50 -69.48 �� +33.32 (+insulin) (10) 
* *** ( * ) +63.44 (-insulin) (1) 
Rhizoma Copitidis ^ ^ ^ - 3 5 . 2 8 (^ insulin) (l) * 
** *** (0.01) +79.03 (-insulin) (0.1) 
Radix Ophiopogonis ~ i i ^ ^ 1 1 : (=sulin) 
m *** *** (c\ 1 \ (u.ui) 
… - � -3.81 (-insulin) (0.1) 
Radix Trichosanthis ；;;^ ^ ^ “ 
(5) *** *** 
Radix 路卯 劝 
Pseudostellariae “ -14.24 -63.02 
氺氺 氺氺 
Rhizoma +19.06 -79.99 -71.58 +39.09 , 
Anemarrhenae (q2) *** *** (0.1) 
Semen Ziziphi . . +202.37 
Spinosae ( f ) -4.30 - 二 (o^oi) / 
Table 3.1 Summary of in vitro studies of fourteen selected traditional Chinese 
herbs. The number blanketed represents the concentration in mg/ml aqueous extract, 
except in B B M V studies with hexane or dichloromethane extracts. Significantly 
different from control: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Chapter 4 Purification of Cortex Moutan 
4.1 Introduction 
With the potent in vitro inhibition of B B M V glucose uptake, bioassay-guided 
fractionation of Cortex Moutan was carried out in order to find the active constituent(s). 
4.1.1 Phytochemical Studies of Cortex Moutan 
Cortex Moutan was a commonly used traditional Chinese herb. The major active 
components inside are divided into five groups: 
1. Acetophenones: 
• Paeonol (Fig. 4.1a(i)) is the major phenolic acetophenone inside Cortex 
Moutan, and some six others minor acetophenones such as 2,5-dihydroxy-4-
methoxyacetophenone (Fig. 4.1a(ii)), acetovanillone (Fig. 4.1a(iii)), 
acetoisovanillone (Fig. 4.1a(iv)), 2,3-dihydroxy-4-methoxyacetophenone (Fig. 
1 
! 
4.1a(v)), resacetophenone and 2,5-dihydroxy-4-methylacetophenone (Fig. 
4.1a(vi)), they exhibited potent antibacterial, anti-inflammatory and 
anticoagulation activities (Lin and Chem, 1991; Lin et al., 1999). 
2. Terpenoids: 
Terpenoids including monoterpenes such as paeonisuffrone (Fig. 4.1b(i)), 
deoxypaeonisuffrone (Fig. 4.1b(ii)), paeonisuffral (Fig. 4.1c), isopaeonisuffral 
and paeonisothujone (Yoshikawa et al., 1994; Yoshikawa et al., 2000); and 
also riterpenoid, mudanpinoic acid A (Fig. 4.Id), were found in Cortex Moutan, 
which have analgesic, sedative and anti-inflammatory effects (Lin et al., 1998; 
Lin et al, 1996). 
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3. Glycosides: 
Several paeonol glycosides are found in Cortex Moutan, including paeonoside 
(Fig. 4.1a(vii)), apiopaeonoside, paeonolide (Fig 4.1e), and different 
suffruticosides (Fig. 4.1e(ii, iii, iv)) (Matsuda et al., 2001). There are also 
monoterpene glycosides, including paeoniflorin (Fig. 4.1f(i)), oxypaeoniflorin 
Fig. 4.1f(ii)), mudanpioside A-F, and their benzoyl or galloyl derivatives, and 
many mudanpiosides (Matsuda et al., 2001; Ding et al., 1999; Yoshikawa et al., 
2000; Lin et al., 1996). Alpha-benzoyloxypaeoniflorin has anti-oxidative effect 
(Ryu et al., 2001). Paeoniflorin was reported for its anti-diabetic effect, by 
reducing basal glycaemia and improving glucose tolerance of STZ-treated rats 
(Hsu et al, 1997). 
4. Tannins: 
1,2,3,4,6-penta-O-galloyl-p-D-glucose (Fig. 4.1g) is one of the galloyl-glucose 
i 
with anti-cancer effect (Wu et al.，2003b). 
i 
5. Polysaccharides: 
One of the polysaccharides called polysaccharide-2b which is present in Cortex 
Moutan has been shown to have hypoglycaemic activity in a diabetic mouse 」 
model(Hong et al., 2003). 
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Fig. 4.1 Structures of compounds found in Cortex Moutan 
(a) i. Paeonol: R1 = OH, R2 = H; R3 = OCH3, R4 = H; 」 
ii. 2,5-dihydroxy-4-methoxyacetophenone: R1 = OH, R2 = H, R3 = OCH3，R4 = 
OH; 
iii. Acetovanillone: R1 = H, R2 = CH3, R3 = OH, R4 = H; 
iv. Acetoisovanillone: R1 = H, R2 = OH, R3 = CH3, R4 二 H; 
V. 2,3-dihydroxy-4-methoxyacetophenone: R1 = OH, R2 = OH, R3 = OCH3, R4 
= H ; 
vi. 2,5-dihydroxy-4-methylacetophenone: R1 = OH, R2 = H, R3 = CH3, R4 = 
OH; 
vii. Paeonoside: R = P-D-glucopyranosy 1; 
(b) i. Paeonisuffrone: R = OH; ii. Deoxypaeonisuffrone: R = H; 
(c) Paeonisuffral; (d) Mudanpinoic acid A 
(e) i. Paeonolide: R1 = R2 = R3 = H; 
ii. Suffruticoside C: R1 二 R2 = H, R3 = galloyl 
iii. Suffruticoside D: R1 = R3 = H, R2 = galloyl; 
iv. Suffruticoside E: R1 = P-D-glucopyranosyl, R2 = R3 = H; 
(f) i. Paeoniflorin: R = H; ii. Oxypaeoniflorin: R = OH; 
(g) 1,2,3,4,6-Penta-O-galloyl-P-D-glucose: R = galloyl 
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4.2 Organic Extraction of Cortex Moutan 
4.2.1 Extraction Material and Methods 
One and a half kilograms of raw material of Cortex Moutan were cut into small 
pieces and covered with 2.5L of 95% EtOH (EtOH-HsO, 95:5, v/v; Uni-Chem, South 
Keamy, NJ, USA). After refluxing for two hours, the extract solution was collected and 
fresh 95% EtOH was added for another two-hour extraction. Two extractions were 
combined, and the solvent was evaporated using a rotary evaporator to obtain the 
ethanolic extract of Cortex Moutan (CM-A). 
C M - A was re-dissolved in 500ml distilled water and partitioned with 500ml hexane 
(Lab-Scan, Bangkok, Thailand). Hexane fraction was collected, and the water fraction 
was partitioned again with 500ml of fresh hexane. Two hexane fractions were combined. 
Excess anhydrous sodium sulphate (MERCK, Darmstadt, Germany) was added to 
absorb remaining moisture in hexane extract. The mixture was filtered and the hexane 
i 
extract (CM-C) was dried using a rotary evaporator. The remaining water fraction (CM-
I 
B) was further partitioned with 500ml dichloromethane (Lab-Scan, Bangkok, Thailand). 
Dichloromethane fraction was collected, and the water fraction was again partitioned 
I 
with another 500ml of fresh dichloromethane. Two dichloromethane fractions were ‘ 
combined and the moisture inside was absorbed by excess anhydrous sodium sulphate. 
The mixture was filtered and the dichloromethane extract (CM-D) was dried using a 
rotary evaporator. The water fraction (CM-E) was discarded. A simplified extraction 
procedure was shown in Fig. 4.2. 
4.2.2. Results 
The Cortex Moutan raw material was extracted by 95% EtOH, giving the ethanolic 
extract of Cortex Moutan (CM-A), with extraction yield of 11.68% w/w. CM-A was 
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partitioned between water and hexane. The extraction yields of the hexane fraction 
(CM-C) and dichloromethane fraction (CM-D) from the raw material were 1.33% w/w 
and 1.16% w/w respectively. CM-C was a pale brown solid, and CM-D was yellowish 
brown solid, both with a characteristic odour of raw Cortex Moutan. 
The purification of active component(s) was bio-assay guided according to B B M V 
assay results. As in B B M V assay, any glucose present in the herbal extracts could affect 
the accuracy of the results, hence, non-polar organic solvent was used in extraction and 
partition in order to get rid of undesirable glucose or other sugars. Thus, both CM-B and 
CM-E water fractions were discarded as they might contain glucose which are extracted 
from the herbal extracts. 
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Cortex Moutan Raw Material (1500g) 
95% EtOH extraction 
T 




Water Fraction Hexane Fraction 
(CM-B, discarded) (CM-C, 20.0Ig) 
I T 
Water Fraction Dichloromethane 
(CM-E) Fraction 
discarded (CM-D, 17.35g) 
Fig. 4.2 Organic Extraction Procedure of Cortex Moutan 
J 
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4.3 BBMV Glucose Uptake Assay with Cortex Moutan Organic 
Extract (CM-C and CM-D) 
The anti-diabetic activity of CM-C was confirmed by another student before (data 
not shown) (Lau, 2004). The activity C M - D on B B M V intestinal glucose absorption 
compared with C M - C was studied in order to find out the active component(s) inside 
Cortex Moutan. 
4.3.1 Material and Methods 
The materials and methods were the same as described in section 3.2.2. As both 
CM-C and C M - D fractions were water insoluble, they were re-dissolved in 100% EtOH 
(MERCK, Darmstadt, Germany), and diluted by water to become 4 % v/v EtOH, and the 
final concentration would become 2 % v/v EtOH in the reaction mixture. The 
concentration of herbal extract was 2mg/ml and the final concentration was Img/ml in 
reaction mixture. The result of each treatment was compared against 2 % v/v EtOH 
treatment (as control). Water control was performed to monitor the effect of 2% v/v 
EtOH on glucose uptake of B B M V . 
4.3.2 Results 
The results of B B M V glucose uptake were shown in Fig. 4.3 As proven before, no 
significant difference was found between 2 % v/v EtOH group and the water control 
group, therefore 2% v/v EtOH would not affect the glucose uptake of B B M V and could 
be used as a control. The dosage used for both CM-C and C M - D were 1 mg/ml, and 
they both significantly inhibited glucose absorption of B B M V . 
Chapter 4 Purification of Cortex Moutan 96 
120 




名 8 0 c o 
0 6 0 -
CO •Q < 
& 40 -� 
O) 
iS ** 
1 20 ** I  
O T Q- ±  
0 1 1 ‘ ‘ 
2% EtOH CM-C CM-D I 
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4.4 Fractionation of CM-C and CM-D 
C M - C was fractionated by another student and the pure compound paeonol was 
proven to have anti-diabetic effects in vitro (Lau, 2004). But there may be other 
compound(s) which is responsible for the anti-diabetic effect since the inhibitory effect 
in B B M V assay of paeonol was not as strong as CM-C, so there must be other active 
component(s). Furthermore, as shown in the B B M V intestinal glucose absorption assay 
in the last section, C M - D also significantly inhibited glucose absorption, hence, silica-
gel column-chromatography were conducted on both fractions to further find out the 
active components. The fractionation was guided by B B M V glucose uptake assay. 
Using column-chromatography allowed separation of compounds in a large scale, 
providing adequate amounts of samples for the bioassay and structure elucidation. 
4.4.1 Material and Methods 
4.4.1.1 Chemicals 
j 
Here is the list of the chemicals used in this experiment: 
1. Purchased from M E R C K (Darmstadt, Germany): 
i 
Silica-gel 60, anisaldehyde, glacial acetic acid, and silica-gel 60 F254 pre-coated ‘ 
TLC plate. 
2. Purchased from Lab-Scan (Bangkok, Thailand): 
Methanol (MeOH), hexane and ethyl acetate (EtOAc). 
3. Purchased from B D H Laboratory Supplies (Poole, UK) 
Concentrated sulphuric acid (H2SO4). 
4.4.1.2 Methods 
Fractions CM-C (6g) and CM-D (6g) were completely dissolved in MeOH, and 
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mixed with lOg silica-gel 60 respectively. The solvent was completely dried by rotary-
evaporator to obtain the mixtures of CM-C/silica gel and CM-D/silica gel in powder 
form. 
One hundred and fifty grams of silica-gel 60 were mixed with the eluent (hexane-
EtOAC, 7:3, v/v). The mixture was loaded in a glass column and until the silica gel was 
tightly packed inside the column. The length of column was 400mm and the diameter 
was 320mm. CM-C/silica gel or CM-D/silica gel mixture was gently placed on top of 
the column. The column was then eluted with the eluent under gravity. Fractions were 
4 
collected by a fraction collector and the fractions collected were pooled together 
according to the chemical profile of fractions by thin layer chromatography analysis. 
Finally the column was flushed with 100% EtOAc in order to elute all the remaining 
substances inside the column. Fractions were completely dried with a rotary evaporator 
and weighed. 
i 
For TLC analysis, silica gel 60 F254 on aluminum sheets was used as the stationary 
phase, and the mobile phase components were same as the eluent of silica gel column 
chromatography (i.e. hexane-EtOAC, 7:3, v/v). For each fraction, samples were applied 
onto a TLC plate at the baseline using a capillary tube, with 1cm space from the bottom 
edge of the plate. 10ml of mobile phase was added to a covered glass chamber. After the 
chamber was pre-equilibrated with the mobile phase for about 5 minutes, the TLC plate 
was placed inside the chamber, and it was then removed when the solvent front of 
mobile phase was about 1cm below the top edge of the plate. The plate was dried, and 
visualized under ultraviolet light (UV), and/or after spraying with different reagent: (1) 
anisaldehyde-sulphuric acid reagent (0.5ml anisaldehyde, 50ml acetic acid, 1ml 
sulphuric acid, freshly prepared) and heating at 100°C for five minutes; or (2) 10% v/v 
H2SO4 in EtOH,and heating at 110°C for 5 minutes. 
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The Rf value was determined and the colour of each spot on TLC plate was then 
recorded. The calculation of Rf value is shown below: 
Rf value = Distance from baseline to centre of spot 
Distance from baseline to solvent front 
4.4.2 Results 
Both C M - C and C M - D were fractionated using silica-gel column chromatography. 
For CM-C, a total of 98 fractions were obtained, and combined into final 12 ； 
fractions according to their chemical profiles, known as CM-Cl to CM-C 12. The 
weights of fractions were shown in Table 4.1. The heaviest fraction CM-C2 (4.35g) was 
proven to be paeonol by another student (Lau, 2004), whereas for the other fractions, 
the yield was very low. The total yield of all CM-C sub-fractions was 85.22%, the 
relative high yield showed that most of the components had been collected and the 
amount of substance left inside the column was small. 
For CM-D, a total of 95 fractions were obtained, and they were combined into final 
6 fractions according to their chemical profiles, known as CM-Dl to CM-D6. The 
weights of fractions are shown in Table 4.2 The heaviest fraction CM-Dl (4.56g) was 
proven to be paeonol by another student (Lau, 2004), for the other fractions, the yield 
was very low. The total yield of all CM-C sub-fractions was 76.67%, which also 
showed that most of the components had been eluted out. 
The TLC chromatogram of C M fractions was shown in Fig. 4.4. The same amount 
of fraction solution was applied onto the TLC plate. It revealed that most of the 
components inside both fractions were the same. The yellow spot with Rf value of 0.51 
is paeonol. 
In Fig. 4.5，the whole profile of CM-C was shown. Obvious polarity gradient was 
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observed in CM-C profile. There are another 2 yellow spots present in CM-C7 and C M -
OS, which were not clearly seen in Fig. 4.4. It might be due to a small amount present in 
the Cortex Moutan hexane fraction. In Fig. 4.6, CM-D profile was shown. An obvious 
polarity gradient was observed too. CM-Dl was proved to be paeonol, and CM-D3 to 
CM-D6 were all yellow in colour in TLC chromatogram. But there was only one yellow 
spot (except paeonol one) in CM-D, hence, further fractionation was needed. 
I 
I I 
Chapter 4 Purification of Cortex Moutan 101 
~ C M C Fraction Weight (mg) Yield (%) 
1 T m 
2 4335.3 72.26 
3 ^ 
4 ^ r ^ 
5 148.8 ^ 
6 ^ 
7 ^ 
8 r ^ 
9 li^ : 
10 ^ Ol5 
n ^ 0l4 
t 
12 103.7 LTS 
i 
Total 4953.1 8l55 
I 
I 1 
Table 4.1 The table showing the yield of CM-C sub-fractions | 
j 
^^CM-D F r a c t i o n W e i g h t (mg) Yield (%) 
1 4560.0 76.00 
i 
2 o n 
3 O Ol3 
4 KIl 
5 ^ oTi 
6 73 0l2 
Total 4600.2 76.67 
Table 4.2 The table showing the yield of CM-D sub-fractions 
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Fig. 4.4 The TLC chromatogram of CM-C and CM-D. 
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Fig. 4.5 The TLC chromatogram of CM-Cl to 12. 
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Fig. 4.6 The TLC chromatogram of CM-Dl to CM-D6. Left: TLC chromatogram 
sprayed with anisaldehyde-sulphuric acid reagent. Right: TLC chromatogram sprayed 
with 10% v/v H2SO4 in EtOH, brown colour indicated that those were phenoic 
compounds. 
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4.5 BBMV Glucose Uptake Assay of CM-C and CM-D Sub-
fractions 
The B B M V intestinal glucose absorption of CM-C and CM-D sub-fractions were 
tested in this section in order to find out which fraction(s) has most potent anti-diabetic 
effect. All the steps of assay were performed as described in section 4.31. 
4.5.1 Results i 
B B M V glucose uptake assay was performed with the CM-C and CM-D sub-
fractions and results were shown in Fig. 4.7 and 4.8. All fractions of CM-C and CM-D 
(except CM-D2) showed significant inhibition on B B M V intestinal glucose absorption. 
The most potent result in this assay in CM-C sub-fractions was CM-C8, which 
suppressed the glucose absorption into B B M V by 66.6%; while that of CM-D sub-
fractions was CM-D3, which suppressed by 69.0%. 
The B B M V results were compared with the TLC chromatogram (Fig. 4.5 and 4.6). 
It was found that pale yellow spots with Rf value around 0.26 was found in fraction 
CM-C8 and that with Rf values around 0.38, 0.31 and 0.25 were found in fractions C M -
D3 to CM-D5. So it was suspected that the yellow spot should be another active 
component in Cortex Moutan. 
According to Fig. 4.4, as nearly same amount of sample solutions were applied onto 
the TLC plate, hence the amount of each fraction was revealed. The amount of yellow 
spot in CM-C was much less than CM-D. Hence, further investigation was done with 
the CM-D fraction rather than CM-C in order to find out the active component(s) other 
than paeonol (CM-C2 or CM-Dl). 
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Fig. 4.7 Effects of CM C sub-fractions on glucose absorption of BBMV. 2 % EtOH 
served as control. The results are expressed as mean土SD, n=12. Asteristo were used to 
indicate the significantly difference from 2 % v/v EtOH: *p<0.05, **p<0.01, 
***p<0.001. 
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Fig. 4.8 Effects of CM-D sub-fractions on intestinal glucose absorption of BBMV. 
2% EtOH served as control. The results are expressed as mean土SD, n=12. Asteristo 
were used to indicate the significantly difference from 2 % v/v EtOH: *p<0.05, 
**p<0.01, ***p<0.001. 
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4.6 Sulfonylation of CM-D1 
CM-Dl (paeonol), as said before, was proven to have anti-diabetic effect in B B M V 
in vitro. Although it is present in large abundance in Cortex Moutan and has powerful 
anti-diabetic effect, it has a disadvantage in that it is not water soluble. 
Hence, the solubility of organic compound paeonol was increased by sulfonaton 
(Wang and Tang, 1983), and ionic compound sodium paeonol sulfonate (CM-DIs) was 
formed. And then the activity of inhibition of the product in intestinal glucose 
absorption was investigated. 
4.6.1 Materia丨 and Methods 
4.6.1.1 Chemicals 
1. Purchased from Sigma (St. Lousi, M O , USA) 
Paeonol (2-hydroxy-4-methoxyacetopheone), sodium chloride (NaCl) 
2. Purchased from Lab-Scan (Bangkok, Thailand) 
Ethyl acetate (EtOAc), Concentrated sulphuric acid (H2SO4) 
4.6.1.2 Methods 
Sulfonation of paeonol was carried out according to literature record (Hu G, 2004; 
W u et al, 2003a). Paeonol (5g) was mixed with 15ml of conc. H2SO4 in a round bottom 
flask. The mixture was heated at 75°C inside a water bath for 25 minutes with 
continuous stirring. After that, the solution was slowly poured into 500ml distilled water. 
The acidic solution was then extracted with equal amounts of EtOAc for three times, 
and a small amount of active charcoal was added with warming in order to remove the 
colour of the acidic solution. The solution was filtered and 23% (w/v) of NaCl was 
added inside, until all NaCl was dissolved totally, then it was cooled down and 
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crystallized at 4°C. The crystal formed was filtered and dried. The form of the crystal 
was recorded, and the melting point and its solubility was tested. 
4.6.2 Structure Elucidation of CM-D1s 
The structure of CD-Dls was elucidated by proton nuclear magnetic resonance (^H-
NMR), and compared with reference spectra and previous reports. As the melting point 
of C M - D Is was too high for mass spectrometry, only ^H-NMR was done. ^H-NMR 
provided information on the assignment of hydrogen atoms in the studied molecule. 
I 
4.6.2.1 IH-NMR Analysis 
^H-NMR analysis was performed using Bruker (Rheinstetten, Germany) Avance 
DPX300 N M R Spectrometer. Ten milligrams of CM-D Is was dissolved in 0.75ml of 
deuterium methanol (MeOD; Aldrich, St. Louis, M O , USA). The 300MHz ^H-NMR 
spectrum was detected. Chemical shifts were detected relative to reference 
tetramethylsilane. 
4.6.3 BBMV Glucose Uptake Assay of CM-D1s 
The B B M V glucose absorption of CM-D Is was tested to find out its anti-diabetic 
ability of CM-Dl after adding sulfonyl group onto the compound. 
4.6.4 Results 
The product (CM-CIs) collected was white needle shape crystal, with 100% 
yield (1.02g). The melting point of the product was over 200°C and so could not be 
detected. But it was previously reported to be over 320°C (Wang and Tang, 1983). 
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Hence mass spectrometry could not be conducted as it could not be vaporized by mass 
spectrometer. 
The solubility was increased after sulfonation of paeonol, which give a water soluble 
product. The solution was pale yellow. 
The structure of sodium paeonol was shown in Fig. 4.9. The structure was deduced 
from ^ H-NMR spectrum which shown in Appendix 2. 
Fig. 4.10 showed that all concentrations of CM-D Is (0.25, 0.5 and 1 mg/ml) did not 
have significant inhibition on B B M V glucose absorption, while paeonol had significant 
I 
inhibition compared with 2% EtOH control. It proved that although sulfonyl group was 
added, it did not exert any anti-diabetic effect as shown previously. 






Sodium Paeonol Sulfonate 
(2-sulfooxy-4-methoxyacetophenone) 
Fig 4.9 The structure of sodium paeonol sulfonate. ‘ 
Chemical Shift ( 6 ppm) 
Protons CM-Dl CM-Dls 
C2 
O 6.42,s 6.48,s 
« 6.45，d, J=7.5 6.48, d，J=7.5 
^ 7.63,d，J=7.5 8.28,d,^ =7.5 
^ 2.56,s 2.51,s 
O ^ 3.84,s 3,86,s 
cm 
OSO3H 3.23,m 
Table 4.3 Proton assignments of CM-Dl and CM-Dls. 
s — Singlet; d-Doublet; m - Multiple!; J-Coupling constant. 
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Fig. 4.10 Effects of of CM-Dls and paeonol (CM-Dl) on intestinal glucose 
absorption of BBMV. 2 % EtOH served as control. The results are expressed as 
mean士SD, n=12. Asteristo were used to indicate the significantly difference from 2 % 
v/v EtOH: ***p<0.001. 
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4_7 Structural Elucidation of CM-D3, CM-D4 and CM-D5 
Structure of CM-D3, CM-D4 and CM-D5 were elucidated by mass spectrometry (MS) 
and proton nuclear magnetic resonance (^H-NMR), and compared with reference spectra 
and previous reports. As illustrated in Fig. 4.6, the similar colour in TLC chromatography 
which turned brown after sulphuric acid spray indicated that they might be the same type 
of chemical with a phenol group, so we need to clarifiy their structures. 
M S studies provided information on the molecular weight of the tested compounds, 
and that of the fragments generated during electron impact (EI). ^ H-NMR provided 
I 
information on the assignment of hydrogen atoms in the studied molecule. 
4.7.1 Material and Methods 
4.7.1.1 Mass Spectrometry 
Thermo (Bremen, Germany) M A T 95XL Gas Chromatographic Mass Spectrometer 
was used in M S analysis. One milligram of sample dissolved in l|il M e O H was injected to 
the machine. The low resolution EI spectra were obtained for the analysis of compound 
fragments and determination of the molecular weights of the compounds. 
4.7.1.2 ^H-NMR Analysis 
^H-NMR analysis was performed using Bruker (Rheinstetten, Germany) Avance 
DPX300 N M R Spectrometer. Each of the compounds (7 mg) was individually dissolved 
into 0.75ml of deuterium chloroform (CDCI3； Aldrich, St. Louis, M O , USA). The ^ H-
N M R spectra were detected at 300MHz. Chemical shifts were detected relative to 
reference tetramethylsilane. 
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4.7.2 Results 
The low resolution EI spectra of CM-D3，CM-D4 and CM-D5 were shown in 
Appendices 3, 4 and 5，and the ^ H-NMR spectra were shown in Appendices 6，7 and 8. 
Compound CM-D3 was light yellow crystal with molecular formula of C9H10O3, 
which the molecular weight was 166. The melting point was around 145。C to 147°C. 
The peak shown in EI M S (m/z) were 166 [M]+, 151 (100), 137, 123. The ^ H N M R 
(300 Hz, CDCI3) (5H) data was shown in Table 4.4. After comparing data with those 
reported in the literature (Table 4.5)，it was identified as 2,5-dihydroxy-4-
methylacetophenone (Sabui and Venkateswaran, 2003). 
Then for compound CM-D4, it was white crystaline with a molecular formula of 
C9H10O4, which has a molecular weight of 182. The melting point was around 151 °C to 
153。C. The peak shown in EI M S (m/z) were 182 [M]+, 167 (100), 152,139, 124, 111. The 
^H N M R (300 Hz, CDCI3) (5H) data was shown in Table 4.4. It was identified as 2,5-
dihydroxy-4-methyoxyacetophenone after comparing the data with those in the literature 
as shown in Table 4.6 (Kwon et al., 1999). 
For compound CM-D5, it was yellow crystaline with a molecular formula of C9H10O3, 
which has a molecular weight of 166. The melting point was around 88°C -89.5°C. The 
peak data of EI M S (m/z) were 166[M]+, 151(100), 136, 123. And the ^ H N M R (300 Hz, 
CDCI3) (6H) data was shown in Table 4.4. It was identified as 3-hydroxy-4-
methoxyacetophenone (acetoisovanillone) after comparing the data those in the with 
literature as shown in Table 4.7 (Kobayashi et al, 1982). 
All the above compounds belong to acetophenones. The ^ H N M R data of CM-Dl 
(paeonol) was also shown in Table 4.4 for reference and comparison, which was proved to 
be an acetophononic compound too. The structures of the acetophenonic compounds 
purified were showed in Fig. 4.11. 
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(acetoisovanillone) 
Fig.4.11 The deduced structures of CM-Dl (paeonol), CM-D3，CM-D4 and CM-D5 
according to mass spectra and H^ NMR spectra. 
Chemical Shift ( d ppm) 
Protons~ 1 2 3 4 
C2 ‘ 7.53,s 
O 6.42,s 6.77,s 6.44,s 
^ 6.45, d, J=7.5 6.88，d,J=7.2^ 
^ 7.63,d,J=7.5 7.10,s 7.20,s 7.54,d,J=7.2 
^ 2.56,s 2.56,s 2.53,s 2.54,s 
O ^ 3.84,s 3.93,s 3.96,s 
^ ‘ 2.27,s 
Table 4.4 Proton assignments of CM-D3, CM-D4 and CM-D5. 
s - Singlet; d-Doublet; m - Multiplet; J-Coupling constant. 
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D �4 a rit/t m Literature data Protons CM-D3 l • �、 ， … i a a i � (Sabui and Venkateswaran, 2003) 
3H, s, C-CH3 ~ I26 
3H, s，OCH3 
IH, s, H-3 Kfi ^ 
IH, s，H-6 TJO i m 
IH, s, O H 11.86 11.86 
Table 4.5 Comparison of proton assignments of CM-D3 with data from the 
literature. 
: ^ ‘ Literature data 
Protons CM-D4 ‘ , 1 nnn� 
(Kwon et al” 1999) 
3H, s, O二C-CH3 T m 
3H, s，OCH3 I 5 3 
IH, s, H-3 ^ ^ 
IH, s, H-6 
IH, s, O H 
Table 4.6 Comparison of proton assignments of CM-D4 with data from the 
literature. 
Z^TT^ Literature data 
Protons CM-D5 (Kobayashi 招 “/.，1982) 
3H, s, OC - C H 3 ^ ^ 
3H, s, OCH3 ^ ^ 
IH, s, H-2 ^ ^ 
IH, d, H-5 6.88, J=7.2 6 M 
IH, d, H-6 7.54，J=7.2 iJo 
IH, s, O H / / 
Table 4.7 Comparison of proton assignments of CM-D5 with data from the 
literature. 
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4.8 BBMV Glucose Uptake Assay of Acetovallione，CM-D3, CM-
D4 and CM-D5 
After structure confirmation of CM-C3, CM-D4 and CM-D5, another compound 
called acetovanillone (4-hydroxy-3-methylacetophenone) (Fig. 4.12), which was also a 
component found in Cortex Moutan (Li et al, 2004a) with a similar structure with CM-
D6，was purchased from Sigma (St. Louis, MO, USA). It was used to compare activities 
of these fractions and to find out the structure-activity relationship. 
4.8.1 Results 
From Fig. 4.13，all tested compound had a significant inhibitory effect on B B M V 
glucose absorption. The structures of CM-D5 and acetovanillone were similar, and they 
have similar activities in intestinal glucose absorption, which suppressed the glucose 
absorption by 27% and 25% respectively. For paeonol and CM-D3，they also have 
similar structures; they showed strong and significantly suppression of B B M V glucose 
absorption by 64% and 78%, respectively. 





Fig. 4.12 Structure of acetovanillone. 
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Fig. 4.13 Effects of acetovanillone, CM-D and its sub-fractions on glucose 
absorption of BBMV. 2% EtOH served as control. The results are expressed as 
mean土SD, n=12. Asteristo were used to indicate the significantly difference from 2% 
v/v EtOH: ***p<0.001. 
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4.9 Synthesis of CM-D3s 
Although CM-D3 (2,5-dihydro-4-methylacetophenone) was very effective in 
inhibiting glucose absorption in BBMV, its anti-diabetic effect could not be confirmed 
by in vivo model due to its low extraction yield in CM-D fraction (only with 0.13%). 
Moreover, it is not available commercially, and so it could not be purchased. Therefore, 
synthesis of CM-D3 (CM-D3s) was the only way to produce it in relatively large 
amounts for in vivo assays. 
4.9.1 Material and Methods 
4.9.1.1 Chemicals 
Here is a list of the chemicals used in this experiment: 
1. Purchased from Aldrich (St. Louis, MO, USA) 
(2,5-diacetoxytoluene) 2-methylhydroquinone diacetate 
2. Purchased from Lab-Scan (Bangkok, Thailand): 
Methanol (MeOH), hexane and ethyl acetate (EtOAc). 
3. Purchased from B D H Laboratory Supplies (Poole, UK) 
Concentrated hydrochloric acid (HCl) 
4.9.1.2 Methods 
2-Methyhydroquinone diaacetate, on Fries arrangement followed by 
monomethylation should produce 2,5-dihydroxy-4-methylacetophenone (Sabui and 
Venkateswaran, 2003). 
A finely powdered mixture of 2-methylhydroquinone diacetate (20g，96mmol) and 
anhydrous aluminium chloride (43g, 321 mmol) was heated slowly with stirring in an 
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oil bath to 110。C -120。C and kept at this temperature for 30 minutes. Then the 
temperature was increased to 160。C-165。C and kept for 3 hours. The reaction mixture 
was then cooled and decomposed by 150g of crashed ice, and then with 15ml of 
concentrated. HCl. The resulting solid was filtered and washed with 30ml of cold 
distilled water for three times. The product was crystallized from absolute EtOH to 
yield 2,5-dihydroxy-4-methylacetophenone. 
4.9.2 Structure Elucidation of synthesized product 
Structure of the synthesized product was elucidated by mass spectrometry (MS) 
and proton nuclear magnetic resonance (^H-NMR) as described in section 4.8.1，and the 
result was compared with that of CM-D3. 
4.9.3 Results 
The amount of product synthesized in the reaction was 1.1864g, and the yield was 
5.9%. The product was a pale yellow solid, with its melting point of 147.5°C-148.5°C. 
Appendices 9 and 10 showed the results of mass spectrometry and ^ H N M R . The 
peak shown in EI M S (m/z) were 166 [M]+, 151 (100), 137，123. The 'H N M R (300 Hz, 
CDCI3) (5H) data was shown in Table 4.8. After comparing with data with those 
reported in the literature, the result matched well with that of CM-D3, and hence it was 
proved that the product should be 2,5-dihydroxy-4-methylacetophenone (CM-D3). 
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Literature data 
Protons Synthesized CM-D3 (Sabui and 
product Venkateswaran, 
2003) 
3H, s, C-CH3 ^ 五6 
3H, s, OCH3 ^ Z M 
IH, s, H-3 ^ ^ ^ 
IH, s, H-6 TJO 7A0 i m 
IH, s, O H i T ^ I L ^ i T ^ 
Table 4.8 Comparison of proton assignments of synthesized 2,5-dihydroyl-4-
methylacetophenone and CM-D3 with data from the literature. 
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4.10 Discussion 
Sodium paeonol sulfonate was synthesized by reacting with conc. H2SO4 It was 
shown to be water soluble as it was an ionic compound. It had an antibiotic effect 
(Wang and Tang, 1983; W u et al, 2003a), inhibition on calcium influx in heart muscle 
(Tang and Shi, 1991;Wang and Tang, 1983), analgesic, antifebrile and antiphlogistic 
effects (Wang and Tang, 1983). However, there is no anti-diabetic effect has been 
reported. 
In our study, it did not inhibit glucose absorption in the B B M V assay. The 
difference between paeonol and sodium paeonol sulfonate was only changing the 
hydroxyl group on carbon-2 position into sulfonyl group. Therefore, the change in 
structure and functional group of paeonol would lose the activity in its inhibitory effect 
on intestinal glucose uptake. 
As previous study by another student (Lau, 2004) showed that the inhibitory effect 
of CM-C on glucose absorption activity was much higher than that of paeonol, hence it 
was suspected that there should be another active component that exert the inhibitory 
effect in B B M V assay together with paeonol. Also in Fig. 4.13, it also showed the 
inhibitory activity of paeonol was not as strong as CM-D fraction thus supporting the 
previous study. 
After extraction with hexane and dichloromethane, it was found that there was 
another active component found in a range other than that of paeonol that was present in 
Cortex Moutan organic extracts. The TLC chromatogram showed that the active range 
should come from a yellow spot (refer to Fig. 4.4, 4.5 and 4.6). We could also see that 
the amount of that suspected active component was higher in concentration in the 
dichloromethane extract; thus, isolation of that yellow part was carried out in the 
dichloromethane extract (CM-D). 
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All CM-D3, CM-D4, and CM-D5 isolated from CM-D belong to acetophenones, 
which were the same as paeonol. They showed anti-aggregation activity in rabbit 
platelets (Lin et aL, 1999). They all showed positive and significant results in B B M V 
assay, and CM-D3 had the greatest extent. This anti-diabetic effect of CM-D3 had been 
reported before. Very few reports were done on acetophenoic compounds purified from 
Cortex Moutan as they were only minor components inside Cortex Moutan. 
Due to the very low yield in CM-D3 extraction from the herb, synthesis of 2,5-
dihydroxy-4-methylacetophenone (CM-D3s) was performed. The product was then used 
to conduct O G T T to investigate its anti-diabetic effect in vivo. Results are shown in the 
next chapter. 
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Chapter 5 In vivo Studies on Selected Herbs 
5.1 Introduction 
The herbs showing the most promising effects according to results in the various in 
vitro assays were studied with an in vivo model to confirm their anti-diabetic effects. In 
this project, diabetic animal model was used to conduct the in vivo studies in order to 
investigate the anti-diabetic effect of traditional Chinese herbs. Animal studies were 
approved by the Animal Experimentation Ethics Committee, C U H K (02/022/MIS). 
From the in vitro studies, Rhizoma Copitidis, Radix Ophiopogonis, and Cortex 
Phellodendri were chosen to further study in diabetic animal model. Moreover, Cortex 
Moutan, Rhizoma Smilacis Chinensis, and Rhizoma Alismatis mixture were also 
studied in this model to explore their synergistic anti-diabetic effects. And for the 
compound CM-D3 which purified from Cortex Moutan and acetovallione were also 
studied in animal model to confirm their in vitro results. 
5.1.1 Diabetic Animal Models 
Animal models have been used extensively in diabetes research for many years, and the 
research are carried out under control of various legal and ethical restrictions (Rees and 
Alcolado，2005). The diabetes animal models available nowadays are including non-
human primates, dogs, cats, rats, mice, guinea pigs, rabbits and hamsters (Melby and 
Altman, 1976; Rees and Alcolado, 2005). Rats and mouse are most commonly used as 
they are easier to handle and also the cost is lower compared to larger animals. There 
are two main types of diabetic animal models: chemically induced and genetically 
defective. For type 1 D M models, it is usually carried out with animals having total 
insulin deficiency; and for type 2 D M models, it usually has insulin resistance, and 
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retains the ability to release a certain amount of insulin. 
The genetically defective diabetic animal models are made by mutations of several 
diabetes related genes, such as insulin, insulin receptor, glucokinase and mitochondrial 
tRNA (Elbein, 1997). Some of the rodent models are monogenic, such as db/db mice 
(Dong et al, 1997) and zucker fatty rat, and some of them are polygenic, such as Goto-
Kakisaki (GK) rat (Sone et al., 2001) and NZO/HlLt mice (Leiter and Reifsnyder, 2004). 
In recent years, molecular technique produces many new type of knock-in, generalized 
knock-out and tissue-specific knockout mice, such as IR/IRS-l+z— mice (Mcintosh and 
Pederson, 1999). 
For the chemically-induced diabetic models, their pancreatic P-cells are usually 
partially damaged with diabetogenic toxins such as alloxan, streptozotocin, vacor, 
dithizone and 8-hydroxyquinolone (Rees and Alcolado, 2005), so that insulin 
production was suppressed and led to diabetes. In this project, streptozotocin-induced 
type 2 diabetic rat model was employed. Streptozotocin (STZ, 2-deoxy-2-(3-methy 1-3-
nitrosoureido)-D-glucopyranose) is a nitrosurea derivative isolated from Streptomyces 
achromogenes with broad-spectrum antibiotic and anti-neoplastic activity (Bono, 1976). 
It is commonly used as it has selective destruction ability of pancreatic P-cells 
(Gunnarsson et al., 1974; Gunnarsson and Hellerstrom, 1973). It is a powerful 
alkylating agent that has been shown to interfere with glucose transport (Wang and 
Gleichmann, 1998)，glucokinase function (Zahner and Malaisse, 1990). STZ could be 
injected intraperitoneally (i.p.) and absorbed by the pancreatic p-cells through the 
glucose transporter 2 (GLUT2) (Eisner et al., 2000), it exerts its effect by several 
pathways. The main cause of p-cell should be methylation of p-cell DNA, which 
carbonium ions (CH3+) generated by decomposition of the nitrosurea group of STZ 
(Eisner et al., 2000). STZ also acts as a nitric oxide (NO) donor (Kwon et al., 1994; 
Chapter 5 In vivo Studies on Selected Herbs 124 
Kroncke et al, 1995), that damages p-cell when N O is metabolized (Pieper et al., 1999; 
Kroncke et aL, 1995). 
A single large dose of STZ can produce diabetes in rats, probably as a result of 
direct toxic effects, leading to partially insulinopenic diabetes (Rees and Alcolado, 
2005). 
5.1.2 Neonatal Streptozotocin-induced Diabetic Rat Model 
Type 1 D M would be produced if STZ is injected to adult rats due to total 
destruction of P-cells (Rodrigues et al., 1999)，However, type 2 D M would be produced 
if STZ is injected to neonatal rats. Regeneration of neonatal p-cells after STZ-induced 
destruction is incomplete but nevertheless leads to mild to moderate diabetic condition 
and hyperglycaemia. This p-cells regeneration only happens within a few days after 
birth, and once the rats grow into adult stage, part of the P-cells activity and its insulin 
production ability restores at some extent, and has similar situation as type 2 D M (Wang 
et al., 1996). And when p-cells are destroyed on day 2 (n2) or 5 (n5) instead of the day 
of birth (nO), p-cells capacity for regeneration declines rapidly. As nO-STZ rats can 
regenerate more p-cells than n5-STZ rats, the diabetic condition and hence deviation of 
blood glucose level of n5-STZ rats is more severe than that of the nO-STZ rats 
(Mcintosh and Pederson, 1999). Wistar neonatal-STZ induced diabetic models by 
intraperitoneal (i.p.) injection were most commonly used (Blondel et al., 1989; Kergoat 
and Portha, 1985). The pancreatic insulin content of the n5-STZ Wistar rat is 90% 
depleted at the age of 10 weeks while that of the nO-STZ is only 50% depleted at the 
same age (Blondel et al., 1989). 
The disadvantage of chemically induction is mostly due to the fact that the diabetic 
status of the rats is not stable enough as time pass by, but the advantages of using 
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chemical-induced diabetic models are more cost-effective and severe in diabetic 
condition, hence STZ-induced diabetic rats are used in the project. 
5.2 Oral Glucose Tolerance Test (OGTT) 
Improving oral glucose tolerance is one of the modes of action for diabetic 
treatment. For diabetes patients, blood glucose level measured in O G T T should be 
equal or over 11 .OmM. The nO-STZ Wistar rats were used in this study as they have 
moderate diabetic condition with impair glucose tolerance. Herbal water extract was 
applied to the rat model and investigated on their oral glucose tolerance improvement 
effect. 
5.2.1 Animal 
Neonatal female albino Wistar rats were supplied by and kept in The Laboratory 
Animal Service Centre, The Chinese University of Hong Kong. Three to four rats were 
kept in a wire-bottomed cage, in a room with 12-hour light-dark cycle and 22-25°C. 
Normal rodent diets (Prolab 2500 rodent diet) and tap water were constantly supllied to 
the rats. Bedding under the cage was changed at least twice a week. 
5.2.2 Rat Induction Material and Methods 
Rats at day of birth were injected with STZ in citrate buffer (pH 4.5) at a dose of 
100 mg/kg body weight in i.p. route. The neonatal rats were grown with their mother 
until week 6, and then separated from their mother. The rats were ready for use at week 
10-12. 
Streptozotocin, citric acid monohydrate, citric acid trisodium salt dihydrate, 
metformin and heparin were purchased from Sigma (St. Louis, M O , USA). Glucose 
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Assay kits and lOOmg/dl (5.56mM) glucose standard were purchased from BioSystems 
(Barcelona, Spain). 
5.2,3 Testing Method for diabetic condition of rats 
The 10-12 weeks old (adult stage) nO-STZ diabetic rats were used, and their 
diabetic condition was confirmed by determining the fasting hyperglycaemic state. The 
rats with blood glucose over 7.0mM were recruited in the assay. The herbal water 
extract treatments were given to the rats once daily for eight consecutive days. Oral 
glucose tolerance test was performed and plasma glucose level of each rat was 
determined on day 1 for the acute effect study, and also on day 8 for the chronic effect 
study. 
Firstly, rats were randomized into several groups (n > 6): negative control group 
(water or 0.6% v/v Tween 80, 5 ml/kg body weight), positive control group (metformin, 
200 mg/kg), and different herbal extract treatment groups. The dosages were calculated 
based on the human equivalent doses. 
On day 1 experiment, the rats are fasted for two hours before the experiment started. 
Then, 300|il of blood samples were collected into a 1.5ml microfuge tube containing 
heparin (1250U/ml, 5)al/tube) from tail veins of the rats. Once blood samples were taken, 
the rats were immediately force-fed with different treatments. After 30 minutes, blood 
samples were taken again and the rats were immediately force-fed with glucose solution 
(40mg/ml, 2g/kg and 5ml/kg body weight), and the experiment then started and this 
time was defined as “0 minute". Blood samples were then collected after 15, 30, 45 and 
90 minutes. Rats were kept unfed until the last blood sampling was taken. All blood 
samples should be centrifuged within 30 minutes at 4000xg rpm for five minutes, and 
the supernatant (plasma) was transferred to another centrifuge tube and stored on ice. 
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Rats were force-fed with different treatments on day 2 to day 7 without taking 
blood sample. On day 8, the experimental procedure as same as day 1 was repeated for 
chronic herb effect studies. 
The plasma glucose level was measured by glucose oxidase method. For each 
reaction, 1ml of glucose assay solution aliquoted inside 1.5ml centrifuge tube was pre-
warmed at 37。C. Then, 5|il of sample (plasma sample, distilled water (negative control) 
and lOOmg/dl (5.6mM) glucose standard (positive control)) was added to the warm 
solution and mixed well. After five miuntes incubation at 3TC, the absorbance at 
500nm was measured. The actual glucose concentration in the plasma samples was 
calculated by calibration with a 5.6mM glucose standard. 
Glucose concentration of the plasma sample 
=(Absorbance of plasma sample - Absorbance of distilled water) / 
Absorbance of standard x lOOmg/dl 
The area under the curve (AUC) of glucose level across time in each day was fitted 
to multilevel models. Multi-level models were employed to analyze the rate of change 
of A U C at day 1 and 8 at each time point (t = -30, 0, 15, 30, 45, 60, 90 min) relative to 
baseline (day 0) between the control group and treatment groups. The public domain 
software M I X R E G (University of Illinois at Chicago, Chicago, IL, USA) was used for 
fitting multi-level models. All statistical tests were two-sided, with a significant level of 
0.05. 
5.3.4 Results 
The experimental results of O G T T are shown in Fig. 5.1 to 5.6. Metformin (200 
mg/kg) which acted as the positive control in the experiment, with plasma glucose level 
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significantly lower than that of water on both day 1 and day 8，and hence validated the 
model. 
On day 1 of the experiment, no significant difference between water and Rhizoma 
Coptidis, Cortex Phellodendri, Radix Ophiopogonis and the mixUire of Cortex Moutan, 
Rhizoma Smilacis Chinensis and Rhizoma Alismatis in ratio 1:1:1 (400mg/kg) water 
extract treatment groups was observed as shown in Fig. 5.1, 5.2, 5.3 and 5.4. For 
Paeonol (200mg/kg), acetovanillone (200 and 400mg/kg) and CM-D3 (400mg/kg) 
treatment groups as shown in Fig. 5.5, 5.6 and 5.7, they also showed no significant 
results compared with 0.6% v/v Tween 80 (solvent of the drugs). Our results showed 
that the above treatment groups did not improve oral glucose tolerance in vivo in one 
day acute treatment. But for paeonol (400mg/kg) treatment group (Fig. 5.5), its plasma 
glucose level was significantly lower than that of 0.6% v/v Tween 80 at time point 90 
min, this showed that paeonol (400mg/kg) treatment could improve oral glucose 
tolerance in vivo after 90 minutes of administration in one day acute treatment. 
In day 8 experiment result, no significant difference between water and Rhizoma 
Coptidis, Cortex Phellodendri, Radix Ophiopogonis and the mixture of Cortex Moutan, 
Rhizoma Smilacis Chinensis and Rhizoma Alismatis in ratio 1:1:1 (400mg/kg) water 
extract treatment groups was observed as shown in Fig. 5.1, 5.2, 5.3 and 5.4. For 
acetovanillone (200 and 400mg/kg), as shown in Fig. 5.6, it also showed no significant 
results compared with 0.6% v/v Tween 80. It is concluded that the above treatment 
groups did not improve oral glucose tolerance in vivo after eight days chronic treatment. 
For paeonol (200mg/kg) treatment groups as shown in Fig. 5.5, the plasma glucose level 
was significantly lower than that of 0.6% v/v Tween 80 at time point 30 min; while the 
plasma glucose level of paeonol (400mg/kg) treatment group was significantly lower 
than that of 0.6% v/v Tween 80 at time points 15 and 30 min. This showed that paeonol 
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(200 and 400mg/kg) treatment could improve oral glucose tolerance in vivo in both 15 
and 30 minutes after an eight day chronic treatment. 
After eight days of treatment, body weights of rats in all groups and all sets of 
experiments increased gradually, and no significant difference was found between 
treatment groups and the water group (data not shown). No obvious side effect was 
observed with treatment groups. 
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Fig. 5.1 Oral glucose tolerance test of Rhizoma Coptidis (123mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30, 45，60 and 90 min from rat tail veins. Metformin (200mg/ml) 
was performed as the positive control, and water as the negative control. Results were 
expressed as mean 士SEM, n=7. Asterisks were used to indicate significant difference 
from water control group: *p<0.05, **p<0.01, ***p<0.001 
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Fig. 5.2 Oral glucose tolerance test of Cortex Phellodendri (370mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30, 45, 60 and 90 min from rat tail vein. Metformin (200mg/ml) 
was performed as positive control, and water as negative control. Results were 
expressed as mean 士SEM, n=l 1. Asterisks were used to indicate significant different 
from water control group: *p<0.05, **p<0.01, ***p<0.001 
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Fig. 5.3 Oral glucose tolerance test of Radix Ophiopogonis (205mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30, 45, 60 and 90 min from rat tail vein. Metformin (200mg/ml) 
was performed as positive control, and water as negative control. Results were 
expressed as mean 士SEM, n=\2. Asterisles were used to indicate significant different 
from water control group: *p<0.05, **p<0.01，***p<0.001 
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Fig. 5.4 Oral glucose tolerance test of mixture of Cortex Moutan, Rhizoma 
Smilacis Chinensis and Rhizoma Alismatis in ratio 1:1:1 (400mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30’ 45, 60 and 90 min from rat tail vein. Metformin (200mg/ml) 
was performed as positive control, and water as negative control. Results were 
expressed as mean 士SEM, n=12. Asterisks were used to indicate significant different 
from water control group: *p<0.05, **p<0.01, ***p<0.001 
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Fig. 5.5 Oral glucose tolerance test of Paeonol (200 and 400mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30, 45, 60 and 90 min from rat tail vein. Metformin (200mg/ml) 
was performed as positive control, and water as negative control. Results were 
expressed as mean 士SEM, n=12. Asterisks were used to indicate significant different 
from water control group: *p<0.05, **p<0.01, ***p<0.001 
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Fig. 5.6 Oral glucose tolerance test of Acetovallione (200 and 400mg/kg) in Day 1 
treatment (upper) and Day 8 treatment (lower). Treatments were administrated to 
nO-STZ Wistar rats immediately after taking first blood sample (0 min), after 30 min, 
40mg/kg glucose solution was force-fed and blood sample was taken at once. Then 
blood was taken 15, 30, 45, 60 and 90 min from rat tail vein. Metformin (200mg/ml) 
was performed as positive control, and water as negative control. Results were 
expressed as mean 士SEM，n=7. Asterisks were used to indicate significant different 
from water control group: *p<0.05, **p<0.01, ***p<0.001 
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Fig. 5.7 Oral glucose tolerance test of CH-D3 (400mg/kg) in Day 1 treatment. 
Treatments were administrated to nO-STZ Wistar rats immediately after taking first 
blood sample (0 min), after 30 min, 40mg/kg glucose solution was force-fed and blood 
sample was taken at once. Then blood was taken 15, 30, 45，60 and 90 min from rat tail 
vein. Metformin (200 mg/ml) was performed as positive control, and water as negative 
control. Results were expressed as mean 士SEM, n=8. Asterisks were used to indicate 
significant different from water control group: *p<0.05, **p<0.01, ***p<0.001 
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5.3 Basal Glycaemia Test 
Lowering the basal glycaemic blood glucose level could be a method in improving 
the diabetic status of the patients. Basal glycaemia test was performed to study the 
effect of herbal extracts on the basal fasting plasma glucose. In this study, n5-STZ 
Wistar rats were used instead of nO-STZ Wistar rats as they had higher basal glycaemia. 
5.3.1 Animal 
Neonatal female albino Wistar rats were used and the method of maintenance was 
the same as described in section 5.2.1. 
5.3.2 Rat Induction Materia丨 and Methods 
Diabetes was induced in rats at the fifth day after birth. Rats were injected with 
STZ in citrate buffer (pH 4.5) at a dose of 70 mg/kg body weight in i.p. route. The 
neonatal rats grew with their mother until week 6, and they were then separated from 
their mother. The rats were ready for use at week 10-12. 
5.3.3 Testing Method 
The 10-12 weeks old (adult stage) n5-STZ diabetic rats were used, and their 
diabetic condition was confirmed by determining the fasting hyperglycaemic state. The 
rats with blood glucose over 7.0mM were recruited in the assay. The herbal water 
extract treatments were given to the rats once daily for eight consecutive days. Oral 
glucose tolerance test was performed and plasma glucose level of each rat was 
determined on day 1 for the acute effect study, and it was also done on day 8 for the 
chronic effect study. 
Firstly, rats were randomized into several groups (n > 6): negative control group 
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(water, 5ml/kg body weight), positive control group (metformin, 200mg/kg), and herbal 
water extract treatment groups (123mg/kg Rhizoma Coptidis, 307mg/kg Cortex 
Phellodendri and 205 mg/kg Radix Ophiopogonis). The dosages were calculated based 
on the human equivalent doses. 
On day 1 of the experiment, the rats are fasted for two hours before the experiment 
started. Then, 300|al of blood samples were collected into a 1.5ml microfuge tube 
containing heparin (1250U/ml, 5|Lil/tube) from the tail veins of the rats. Once blood 
samples were taken, the rats were immediately force-fed with different treatments, and 
the experiment started and this time was defined as “0 minute". Blood samples were 
then collected after 45, 90，135, 180, 240 and 360 minutes. Rats were kept unfed until 
the last blood sampling was taken. All blood samples should be centrifuged within 30 
minutes at 4000xg rpm for five minutes, and the supernatant (plasma) was transferred to 
another centrifuge tube and stored on ice. 
Rats were force-fed with different treatments on day 2 to day 7 without taking 
blood sample. On day 8，the experimental procedure as the same as day 1 and was 
repeated for the chronic herb effect study. 
The plasma glucose level was measured by using the glucose oxidase method. For 
each reaction, 1ml of glucose assay solution aliquoted inside 1.5ml centrifuge tube was 
pre-warmed at 3TC. Then, 5jil of sample (plasma sample, distilled water (negative 
control) and lOOmg/dl (5.6mM) glucose standard (positive control)) was added to the 
warm solution and mixed well. After five miuntes incubation at 37°C, the absorbance at 
500nm was measured. The actual glucose concentration in plasma sample was 
calculated by calibration with a 5.6mM glucose standard. 
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Glucose concentration of the plasma sample 
=(Absorbance of plasma sample - Absorbance of distilled water) / 
Absorbance of standard x lOOmg/dl 
The area under the curve (AUC) of glucose level across time in each day was fitted 
to multilevel models. Multi-level models were employed to analyze the rate of change 
of A U C at day 1 and 8 at each time point (t = 45, 90，135, 180, 240, 360 min) relative to 
baseline (day 0) and the results were compared between the control group and treatment 
groups. The public domain software M I X R E G (University of Illinois at Chicago, 
Chicago, IL, USA) was used for fitting multi-level models. All statistical tests were 
two-sided, with a significant level of 0.05. 
5.3.4 Results 
The experimental results of basal glycaemia test are shown in Fig. 5.8. Metformin 
(200 mg/kg), which acted as positive control in the experiment, the plasma glucose level 
was significantly lower than that of water on both day 1 and day 8, and hence validated 
the model. 
On day 1 of the experiment, no significant difference between water and three 
herbal treatment groups were observed (Rhizoma Corptidis, Cortex Phellodendri and 
Radix Ophiopogonis). It showed that three of the above herbal water extracts did not 
exert any hypoglycaemic effect on the basal glycaemia in vivo. 
On day 8 of the experimental, the plasma glucose level of Rhizoma Corptidis 
treatment group was significantly higher than that of the water group at time point 
t=240 and 360 min; also the plasma glucose level of Cortex Phellodendri treatment 
group was significantly higher than that of the water group at time point t=360. On the 
other hand, the plasma glucose level of Radix Ophiopogonis treatment group did not 
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show significant difference with that of water group. Hence it concluded that the herbal 
water extracts did not exert any hypoglycaemic effect on the basal glycaemia in vivo. 
After eight days of treatment, body weights of rats in all groups increased gradually, 
and no significant difference was found between treatment groups and the water group 
(data not shown). N o obvious side effect was observed with the treatment groups. 
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Fig. 5.8 Basal glycaemia test with Cortex Phellodendri, Rhizoma Coptidis, Radix 
Ophiopogonis in Day 1 experiment (upper) and Day 8 experiemnt (lower). 
Treatments were given to n5-STZ Wistar rats immediately after taking first blood 
sample (0 min), then blood was taken 45, 90, 135, 180, 270 and 360 min after treatment 
administrated. Metformin (200mg/ml) was performed as positive control, and water as 
negative control. Results were expressed as mean ±SEM, n=8. Asterisks were used to 
indicate significant different from water control group: *p<0.05, **p<0.01，***p<0.001 
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5.4 Discussion 
The neonatal STZ Wistar rat models were well recognized type 2 diabetes animal 
model (Giroix et al, 1983; Schaffer and Mozaffari, 1999). The glucose induced insulin 
secretion is defective in STZ model by destroying pancreatic P-cells (Rodrigues et al., 
1999). In this project, the nO-STZ rats were used in the oral glucose tolerance test while 
the n5-STZ rats were used in the basal glycaemia test. The n5-STZ rats have more 
severe hyperglycaemia and higher basal glycaemia level then nO-STZ, and hence 
provide a sensitive model for investigating the herbal effect on hypoglycemic study. On 
the other hand, nO-STZ rats have moderate hyperglycaemia and impaired oral glucose 
tolerance which has a similar glycaemic level comprared to human type 2 diabetes, 
hence suitable for oral glucose tolerance test. Both models are glucose intolerance, 
however, insulin resistance is only observed in n5-STZ (Blondel et al., 1990). 
Metformin is an oral hypoglycemic agent, which belongs to the class known as the 
biguanides. Metformin reduces fasting plasma glucose concentration by reducing rate of 
hepatic glucose production via gluconeogenesis and glycogenolysis. (Ashokkumar and 
Pari, 2005). In this animal study, metformin significantly lowered the basal glycaemia 
and improved oral glucose tolerance in neonatal-STZ rats in all set of experiment, hence 
validated the model. Also, several other oral anti-diabetic agents with different modes of 
action, including sulfonylureas and a-glucosidase inhibitors also can validate this STZ 
rat model (Portha and Serradas, 1991; Degirmenci et al., 2002), therefore, this is a good 
animal model which is suitable for studying the anti-diabetic effect of potential drug 
candidates. 
Rhizoma Coptidis, Cortex Phellodendri and Radix Ophiopogonis were chosen from 
the previous in vitro studies as they have shown the most potent anti-diabetic effects in 
those in vitro studies, and their effects need to be further confirmed by an in vivo model. 
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Cortex Moutan, Rhizoma Smilacis Chinensis and Rhizoma Alismatis were studied in 
this assay as they have proven to have promising anti-diabetic effects on various in vitro 
studies which were done by other students (Chan, 2004; Lau, 2004). Each individual 
herbal water extract was already proved to have no improving oral glucose tolerance 
ability by other students. Then in this project, the same amount of each herb was mixed 
together and their synergistic effects were studied. For acetovanillone and CM-D3, they 
are the active components in Cortex Moutan, and acetovanillone did not show any anti-
diabetic effect in the B B M V assays while CM-D3 did. They were subjected to this in 
vivo assay to confirm the in vitro results. 
Among the tested treatments, the water extracts of Rhizoma Coptidis (123mg/kg), 
Cortex Phellodendri (370mg/kg), Radix Ophiopogonis (205mg/kg), mixture of Cortex 
Moutan, Rhizoma Smilacis Chinensis and Rhizoma Alismatis in ratio 1:1:1 (400mg/kg), 
and also pure compounds inside Cortex Moutan acetovanillone (200 and 400mg/kg) and 
CM-D3 (400mg/kg), all did not show any positive effects in OGTT; that is, they have 
no anti-hyperglycaemic effect. The mixture of Cortex Moutan, Rhizoma Smilacis 
Chinensis and Rhizoma Alismatis in ratio 1:1:1 (400mg/kg) did not give any synergistic 
effect on improving oral glucose tolerance. 
Dur to low extraction yield of CM-D3 from Cortex Moutan raw herb, synthere of 
CM-D3 was done. Since the amount of product CM-D3s was not enough for chronic 
study in rat model, only 1 day acute treatment could be studied. 
Furthermore, the water extracts of Rhizoma Coptidis (123mg/kg), Cortex 
Phellodendri (370mg/kg), and Radix Ophiopogonis (205mg/kg) did not give any 
positive effects in basal glycaemia test. But for paeonol (200 and 400mg/kg), it showed 
positive effects on O G T T by both acute (1 day) and chronic (8 days) treatment. Paeonol 
(400mg/kg) had better effect on improving oral glucose tolerance than paeonol 
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(200mg/kg) in its chronic treatment. 
The dosage used in herbal water extracts was equivalent to the human dosage 
recorded in Zhong Hua Ben Cao (中華本草）and the State Pharmacopoeia Commission 
(State Pharmacopoeia Commission, 2000). Since the dosage reported is for raw herb, 
hence the amount of herbal treatments in the tests of this project are already very high as 
herb extract were used. 
Comparing with the various results of in vitro studies, all the above treatments did 
not exhibit any acute or chronic anti-diabetic effects in vivo. The great difference 
between the in vitro results and in vivo results might be due to several possible reasons, 
including the presence of glucose in the herbs which will hinder their anti-diabetic 
effects; active component(s) inside herbs could not be absorbed through the digestive 
system; the active component(s) is broken down during digestion; the dosage of each 
treatment was not suitable. The dosage was, although equivalent to human dosage, still 
not correlated to the results of in vitro studies; also it is difficult to calculate the dosage 
used from in vitro tests and then apply to the in vivo model. Variations between 
individual rats would also decrease the power of statistical analysis, and large sample 
size should be employed in order to achieve the reliable results with lower standard 
deviation. Due to the presence of a small amount of glucose inside the herb, the active 
component(s) could not show strong anti-diabteic effect in the animal model. Metformin, 
as a pure compound, on the other hand could show a significant anti-diabetic effect in 
this animal model. 
The limitations of this STZ diabetic rat model could also take part in these 
disappointing results. Hypoinsulinaemia is present instead of hyperinsulinaemia in this 
model as STZ chemically destroy pancreatic P-cells. Insulin resistance was only found 
in n5-STZ rats but not in nO-STZ rats, so nO-STZ rats cannot totally represent the real 
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situation in type 2 diabetes patients. As mentioned before, the blood glucose level, i.e. 
diabetic status of the STZ diabetic rats are not stable, the blood glucose will increase as 
the age of rats increased (over 14 weeks). 
To improve the results and for further study, genetic type 2 diabetic animal models, 
such as dbldb mice, Zucker fatty rats and Goto-Kakisaki rats could be used. 
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Chapter 6 General Discussion 
6.1 Introduction 
Type 2 D M is a major health problem worldwide with great prevalence (King et al., 
1998). Many western oral medications were invented to control blood glucose level by 
means of different mode of actions, but they have adverse side effects. N e w medicine is 
needed with less side effects and better effectiveness. Traditional Chinese herbs are used 
for many years and with much less side effects. 
A common complication among elderly patients suffering from diabetes mellitus is 
ulceration of the foot. Considering the disadvantages of limb amputation of D M patients 
who have serious foot ulcer with uncontrolled blood glucose level, two Chinese herbal 
formulae were designed by an herbalist from the Shanghai Institute of Integrated 
Western and Chinese Medicine, in order to reduce the chance of limb amputation by 
improving the wound healing. Formula 1 (托毒生肌湯）was designed to strengthen 
muscle and control swelling; Formula 2 (著味地黃湯 ) w a s used to promote 
regeneration of muscle and tissues (Wong et al., 2001). The herbs were listed in table 
1.3. But the original reason of foot ulcer is diabetes mellitus, hence investigate of those 
herbs on their anti-diabetic effects could be another way to reduce the chance of foot 
ulcer by lower the blood glucose level of those patients. 
There are also another traditional herbal formulae used in China for many years in 
treating D M . These twelve herbal formulae are listed in appendix 1. Fourteen herbs 
were chosen from these formulae according to their dosage and frequency of use among 
twelve formulae (Table 1.2). 
By using scientific approach, investigation of anti-diabetic effect of different 
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traditional Chinese herbs was done. 
1. Screening the potential anti-diabetic herbs with the use of four in vitro 
models, namely H4IIE hepatoma cells, B B M V , Hs68 human foreskin 
fibroblasts and 3T3-L1 adipocytes. They represented different mode of 
actions in regulating blood glucose level, including inhibition of 
gluconeogenesis, suppression of intestinal glucose absorption and 
enhancement glucose uptake into peripheral tissues. 
2. The most potent anti-diabetic herb was further purified to find out its active 
component(s). 
3. In vivo neonatal STZ diabetic Wistar rat model was used to confirm the in 
vitro results. 
In vitro studies of Formula 1 and Formula 2 were completed by other two 
colleagues (Chan, 2004;Lau, 2004). And the results were showed in Table 6.1. 
From the results, Rhizoma Smilacis Chinensis from Formula 1, Cortex Moutan and 
Rhizoma Alismatis from Formula 2 had most potent anti-diabetic effect in vitro. They 
were chosen out, and further studied in animal model and/or investigated the active 
compound(s) inside the herb which gave the effect. 
In this project, other fourteen selected herbs from traditional herbal formulae 
were studied using same in vitro techniques and screening approach. Three herbs with 
most potent effect were Cortex Phellodendri, Rhizoma Copitidis and Radix 
Ophiopogonis from in vitro assays. 
The criteria of choosing the effective herbs based on: 
1) Positive results in all in vitro studies: 
The reasons of using four in vitro assays as screening mechanism because these four 
models could mimic the glucose homeostasis mechanism inside human body; also 
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Chinese medicine is focus on the improvement of whole body rather than one target 
organ or mechanism. Hence if the herb could give all positive results among four 
models, which mean the chosen herb is all-rounded and worth further studying in 
animal model. 
2) Low effective dosage: 
The herb with lower effective dosage was preferred rather than with high effective 
dosage. It could prevent the toxicity of the herbal extract, and also be more cost 
effective. 
3) Toxicity of the herb 
The herb should have less or no toxicity according to pharmacopoeia. 
According to these criteria, six herbs were chosen out (three from Formula 1 and 2, 
three from other formulae) (Table 6.2). Due to limiting time, only three herbs could be 
chosen from each part. It was reasonable as the final aim of this project is to find out the 
possibility to make a new herbal formula in treating D M , and the new formula should 
be with less than five herbs. 
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Herb Name H4IIE BBMV hs68 3T3-L1  
(Hexane)  
Formula 1 (Chan, 2004) 
^ - 35.40/0 +40.1% + 94.6%^ 
Radix Astragali -二 (1.0) (1.0) (0.1) 
^ + 78.30/0 
Radix Rehmanniae nm nm (⑴.。） (0.01) 
-81.90/0 +51.8% + 87.7% 
Rhizoma Smilacis Chinensis (5.0) •二。 (0.01) (01) 
* U-UJ * * 
-66.30/0 + 26.6% +43.30/0 
Rhizoma Atractylodis Macrocephalae (！ )^ (1.0) (0.01) (0*1) 
-76.7% +43.3% + 5 5 . 4 % ^ 
Radix Polygoni Multiflori Preparata (5.0) 丄丄丄么。 （10) (0 01) 
* \ * y * * 
^ -44.10/0 - 54.2% +1100/0 
Radix Stephaniae Tetrandrae "(o f (1*0) (0.001) ⑴ ” 
Formula 2 (Lau, 2004) 
-80.0% +24.3% + 7 8 . 9 % ^ 
Cortex Moutan " V m (i.。） （。.⑴） 
FructusCorni S f ^ ^ ^ ^ ^ 
‘ 10/ -30.8% +44.9% + 4 7 . 4 % ^ 
Fructus Schisandrae Chinensis . A (1.0) d-O) (0.01) 
W'^J 氺氺氺 氺氺氺 氺氺氺 
^ ^ ^ ^ ^ ^ ^ 
Poria (5.0) (1.0) (*1*0*) 
-33.6% +40.1% + 9 4 . 6 % ^ 
Radix Astragali ^0) (！力） （！力） ⑴.!） 
� K^'^J * * 氺 氺 * * * * * 
^ +78.30/0 
Radix Rehmanniae ？0 2) -0.7% d.O) (lO.O) (O.Ol) 
： ^ - 8 . 2 % (1.0) +1 二 3 。 / 。 ^ ^ 
Rhizoma Alismatis (5 m ** (0.1) (l.O) 
+74 eo/o -16.5% +93.2% +10.6%^ 
Rhizoma Dioscoreae (5.0/ (l.O) (lO.O) (0.01) 
Table 6.1 Summary of in vitro studies of fourteen traditional Chinese herbs from 
Formula 1 and Formula 2. The number blanketed represents the concentration in 
mg/ml aqueous extract, except in B B M V studies with CHCI3 extract of aqueous extract. 
Significantly different from control: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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6.2 Summary of Research Findings 
Before any experimental studies were carried out, authentication was performed to 
prove that all the selected herbs were genuine. 
Among 14 herbs tested, three herbs were selected out namely Cortex Phellodendri, 
Rhizoma Corptidis and Radix Ophiopogonis. They posses the most potent anti-diabetic 
effect among different in vitro screening systems (table 3.1). 
Sodium paeonol sulfonate was synthesized in order to improve the solubility of 
paeonol in water. However, it did not exert the same results as paeonol did in B B M V 
assay. Then purification of active components in Cortex Moutan dichloromethane 
fraction was carried out. 2,5-dihydroxy-4-methylacetophenone, 2,5-dihydroxy-4-
methyoxyacetophenone and 3-hydroxy-4-methoxyacetophenone were isolated, and their 
structures and identities were confirmed by analysis with mass spectrometry and proton 
N M R . They had proved to have inhibitory effects in B B M V assay, 2,5-dihydroxy-4-
methylacetophenone had the most effective inhibitory effect. Together with paeonol, 
they all belong to acetophenones and showed anti-diabetic effects, which was not 
published before. 
Only paeonol (200 and 400mg/kg) showed positive effects on O G T T by both acute 
(1 day) and chronic (8 days) treatment in animal tests. Cortex Moutan, Rhizoma 
Smilacis Chinensis and Rhizoma Alismatis mixture (1:1:1), Cortex Phellodendri, 
Rhizoma Corptidis, Radix Ophiopogonis and CM-D3 (2,5-dihydroxy-4-
methylacetophenone) did not have any anti-hyperglycemic effect. 
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6.3 Result Interpretation 
6.3.1 Result Interpretation of In Vitro Studies 
In Chinese medical theory, formation of diabetes is mainly due to three reasons: 1) 
deficiency ofyin inside stomach; 2) deficiency ofyin inside kidney; and 3) deficiency of 
yif^  inside lung. Hence, the herbs commonly used to treat diabetes should restore yin and 
quench heat inside stomach, kidney and lung. Six herbs were chosen out from in vitro 
studies, they were Cortex Moutan, Rhizoma Alismatis, Rhizoma Smilacis Chinensis, 
Cortex Phellodendri, Rhizoma Copitidis and Radix Ophiopogonis. And among these six 
herbs, they all have similar properties that they are "slightly cold" or “cold，，in nature 
and can enhance fluid formation (yin-nourishing effect). 
Radix Ophiopogonis would be the most commonly used one. It belongs to the 
lung, stomach and heart meridian. It exerts the action by quenching heat in qi and lung, 
and help improving the feeling of thirsty, dry mouth (dehydration) and hungry. As it 
runs inside stomach meridian after application, it may explain that the inhibitory effect 
on B B M V glucose absorption is due to this phenomenon. 
Cortex Moutan is the second most commonly used herb among the chosen herbs. 
It belongs to the kidney, liver and heart meridian. It exerts the action by removing 
pathogenic heat from blood, prevents insomnia, restlessness and reduces the feeling of 
thirsty. As the effect Cortex Moutan is carried through liver meridian, it maybe related 
to the strong inhibitory effect in gluconeogenesis in liver. 
Rhizoma Alismatis belongs to the kidney and urinary bladder meridian, and 
used to quenching heat in lymphatic system. It could enhance yin restoration in kidney, 
hence improve the water homeostasis. This herb showed the most promising effect on 
Hs68 fibroblast glucose uptake enhancement, but it cannot find any relationship from 
the Chinese medical theory, it may imply that it is a new effect to be discovered. 
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For Cortex Phellodendri and Rhizoma Copitidis, they are both "cold" in nature, 
and they are rarely used in D M comparatively unless the patients have extreme heat in 
stomach Cortex Phellodendri belongs to large intestine, kidney, and urinary bladder 
meridian, while Rhizma Copitidis belongs to stomach, large intestine, liver and heart 
meridian. Their actions are both clearing of latent-heat and clearing damp. These two 
herbal extracts showed strongest effect in B B M V intestinal glucose absorption 
inhibition, which match that the actions of these two herbs are mostly in digestive 
system. 
And Rhizoma Smilacia Chinensis is not a widely used traditional Chinese herb. 
It belongs to liver and kidney meridian. It can clear damp. The herbal water extract of 
this herb can inhibit the gluconeogenesis in liver, as Chinese medicine theory regards it 
as a liver meridian running herb. 
There are some differences between our research findings and other reported data 
among the three potent herbs chosen using in vitro screening studies. For 3T3-LI 
glucose uptake study, it had been reported that crude extracts of Cortex Phellodendri 
and Radix Ophiopogonis could enhance uptake of 2-DOG by percentages of 142 
(0.1 mg/ml), 132 (Img/ml), 24 (lOmg/ml) and 489 (0.1 mg/ml), 374 (Img/ml), 344 
(lOmg/ml), respectively in non-insulin-stimulated cell. In insulin-stimulated cells, the 
percentage of 2-DOG uptake was measured and found to be 747 (0.1 mg/ml), 523 
(Img/ml), 33 (lOmg/ml) and 753 (0.1 mg/ml), 740 (Img/ml), and 421 (lOmg/ml), 
respectively. That indicated that Radix Ophiopogonis increased the glucose uptake in 
basal and insulin-stimulated 3T3-L1 adipocytes (Hong et al., 2000). However in our 
research result as shown, both Cortex Phellodendri and Radix Ophiopogonis did not 
stimulate glucose uptake into 3T3-L1 adipocytes in both insulin treated and non-insulin 
treated cells. The main reason for the contradict any results should be due to the short 
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herbal extract incubation time (30 minutes) in our study, while another report mentioned 
above used one hour for incubation. 
6.3.2 Result Interpretation of Cortex Moutan Purification 
It was proved that hexane fraction of Cortex Moutan had significant anti-
hyperglycaemic effect in STZ rat model (Lau, 2004). That means there was active 
component(s) inside Cortex Moutan. According to this hypothesis, further fractionation 
was done. 
B B M V assay was applied in the bioassay-guided fractionation, so to isolate active 
compound(s) stepwise and the most potent fraction was selected according to B B M V 
results. 
Further fractionation of Cortex Moutan was made from dichloromethane fraction 
(CM-D) rather than hexane fraction (CM-C). It was because the amount of suspected 
active component(s) inside C M - D fraction was shown to be more than that of CM-C in 
thin layer chromatogram (Fig. 4.4). Then five fractions namely CM-Dl to CM-D5 were 
purified. 
The percentage yield CM-D3 purified was very low (around 0.13%). Although it is 
a known compound, it is not available commercially. Hence synthesis was needed in 
order to provide enough amount of CM-D3 for in vivo study. 
Acetovanillone (apocynin) is a known compound inside Cortex Moutan. It is a 
N A D P H inhibitor (Riganti et al., 2005), and had a potent anti-inflammatory activity was 
found in rats with experimentally induced local or systemic inflammation (Hart and 
Simons, 1992). Under the purification condition in this project, it was not purified from 
hexane or dichloromethane fractions. As it also belongs to acetophenone family, it was 
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purchased and studied together with other acetophenones purified, so the actions 
between each structurally similar compound can be made. 
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Fig. 6.1 Oral glucose tolerance test with Cortex Moutan fraction CM-C. (a) Day 1 
acute experiment and (b) Day 8 chronic experiment. Metformin (200mg/kg) and CM-C 
(200mg/kg) showed significant anti-hyperglycaemic effects on both days. Results 
expressed as mean 士 SEM, n = 18 to 22. Significantly different from water control: * p 
< 0.05, ** p < 0.01, *** p < 0.001. 
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6.3.3 Result Interpretation of In Vivo Studies 
In other reseach studies about in vivo assays, Berberine, which is an active 
component of Rhizoma Coptidis, showed anti-hyperglycaemic in normal rats with 
i.p.glucose injection (Chen and Xie, 1986). And the polysaccharides isolated from 
Radix Ophiopogonis could significantly lower the blood glucose in alloxan-induced 
diabetic mice (Zhang and Wang, 1993) In our result as shown, there was no significant 
effect in anti-hyperglycaemia in O G T T with Rhizoma Coptidis nor Radix Ophiopogonis 
treatment rat groups. It might be due to two reasons: (1) the treatment used was only 
herbal water extract, hence the effect was not as strong as pure compounds; and (2) the 
dosages used were not high enough. 
In vivo model showed that Cortex Moutan water extract (388mg/kg) had a trend to 
lower the blood glucose; for Rhizoma Alismatis and Rhizoma Smilacia Chinensis, 
although they exerted no effect in STZ model, but they show significant anti-diabetic 
effect in vitro (Lau, 2004), hence they were brought to synergistic effect study. But 
there was no synergistic effect showed in this study under ratio 1:1:1. This might be due 
to the mixture was made by mixing equal amount of individual herbal extract rather 
than extracted the raw herbs together. 
For the acetophenones, from the in vivo results showed only paeonol exerted anti-
hyperglyaemic effect in STZ rat model but CM-D3 and acetovanillone did not. There 
are several reasons leading to this result: 
1. Structure-activity relationship 
The structures of the above three compounds have high degree of similarity 
(Fig 6.2). When considering also CM-D4, CM-D5 and sodium paeonol sulfonate, 
we could make some hypothesis to explain the activity of paeonol. First, there 
should be a methoxy group at C4 position, a hydroxyl group at C2, and also with no 
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functional group on C5 position. For CM-D3, it had strong inhibitory effect in 
B B M V assay, but it did not have any effect in STZ rat model upon 1 day acute 
treatment. It did not have methoxy group in C4 but a methyl group instead; and 
there was a hydroxyl group on C5 position. These might be the crucial factors which 
affected its activity in animal model. For acetovanillone, the reasons were almost 
the same: it did not have methoxy group at C4 and had an empty C2 position. 
2. Metabolism of Cortex Moutan active components in rats (Gjertsen et al., 
1988;Yasuda et al, 1999) 
There are some research about metabolism of paeonol and acetovanillone inside 
rat model. Each of the compounds was orally administrated to rats of dosage of 
Immol/kg, and the amount of the acetophenones and their derivatives were 
investigated in the excretory product. Paeonol was metabolized more extensively 
and larger amounts of demethylated (resacetophenone) and hydroxylated (mainly 
2,5-dihydroxy-4-methoxyacetophenone CM-D4 and a trihydroxyacetophenone) 
metabolites were excreted. Paeonol did not find to have ketone reduction. 
Acetovanillone was rapidly excreted in the urine, mainly unchanged but also as the 
demethylated compound and three ring-hydroxylated metabolites. Minor additional 
metabolic pathways produced the para-methoxy derivatives, acetoisovanillone etc.. 
Ketone reduction occurred to form dimethoxy-hydroxy derivative and 1 -
phenylethanol derivatives. The metabolites were excreted mainly as glucuronide 
and/or sulphate conjugates. And the unchanged paeonol and acetovanillone mostly 
excreted in urine after 48 hours of application with percentage of 97% and 61% 
respectively. These facts reveal that paeonol as its structure could be altered during 
digestion, which meant it was being used and it could exert the effect to inhibit 
glucose absorption in digestive system; while acetovanillone, it was mostly excreted 
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out of the rat body, it could not exert effect on digestive system to stop glucose 
absorption. These facts might help to explain the negative result on O G T T of 
acetovanillone. 
This project confirms the anti-diabteic effect of paeonol which was previously 
studied by another student. For the other three acetophenoic compounds isolated from 
Cortex Moutan, they are first reported to have inhibitory effect in B B M V assay. For 
CM-D3, the anti-diabetic effect in animal model needs to be further studied, as the 
sample number was not large enough to conclude the effect. 
Chapter 6 General Discussion 159 
• •。严 0 ^ C H 3 。 CH3 
y ] 
6 2 | 
^ ^ HO-^ ^^ ho-^^Y X^^ -^ OH 
OCH3 CH3 OCH3 i c H 3 
Paeonol CM-D3 CM-D4 CM-D5 
2^ -dLhydro3ty-4 23-4Uiydroxy-4 3-hydroxy-4 
-methylace tophe no ne -methoxyacetopheoifte -methoxy acetophenone 
0 CHa 0 \ z 
OH 
0CH3 
Sodium paeo luol sulfonate Acetovanillone 
2-sulfbxy-4- metho xy ace top henoite 4-kydro xy-3-me thoxyajcetop henone 
Fig. 6.2 Structures of acetophenones. 
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6.4 Limitations and Improvements 
In Chinese medical theory, effect of the herb is not only focus on specific 
mechanism or organ, but also improving the symptoms of a disease through several 
mechanisms. Each in vitro model used in this project was only representing one specific 
mechanism. Although four in vitro assays together can give us a relatively complete 
screening system on glucose homeostasis, some hidden mechanisms responding to type 
2 D M formation were still not yet disclosed and studied. Hence, in vitro assays may not 
be the best method to study the effect of the herbs. 
But at this stage, in vitro models still play an important role in Chinese medical 
research. Since traditional Chinese medicine is an experience of ancient people and 
herbalists, it lacks scientific data to support its effect and application rationale. By using 
scientific research techniques, we can support the method of traditional usage of the 
herbs. Also, this screening system with different cell models provided a good method 
for experiment in large scale. Also, in vitro studies were much cheaper and providing 
faster results compared with in vivo study. In vitro study could be a very first step in 
narrowing down the herb list before further investigation in purification and animal 
model. 
There are some limitations on both in vitro and in vivo assays. In B B M V assay, as a 
very small amount of glucose incubation reagent was needed, and hence, it is very 
sensitive to glucose. Any extra glucose (e.g. glucose presence inside herbal water 
extract) would affect the accuracy and gave false positive results. Until now, there is no 
effective way to remove glucose inside herbal water extract without remaining many 
other components. Hence non-polar solvents such as hexane and dichloromethane were 
used as extraction medium as glucose could not dissolve in them. 
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In 3T3-L1 glucose uptake assay, the degree of differentiation of 3T3-L1 cells 
varied between each experiment. It was observed that the degree of differentiation was 
greatly related to number of passage in cell culture. The cells would grow and 
differentiate better under smaller passage numbers, and so it is better to keep the 
passage number not higher then 
The diabetic stage of the in vivo model used in this project was not steady enough, 
the blood glucose level increased as the age of rat increased (serious complications such 
as retinopathy would occur). As a result, chronic treatment could not be studied in this 
model. Another in vivo model such as genetic diabetes mice should be employed as they 
have much more steady blood glucose level. 
The theory of traditional Chinese medicine does not focus on specific illness, but to 
improve the yin and yang balance, and also qi restoration on whole body, so as to 
achieve the recovery of special organ, and maintain balance of different part of body. 
The traditional Chinese herbs usually exert a slow action in improving symptoms of an 
illness, rather than giving an acute response (Lei, 2003). Moreover, formulae with more 
than one herb are commonly used in treatment to give a synergistic effect rather than 
having one single herb as the effect of one herb is not strong enough. Interactions 
between each herb in formulae may also give rise to new compounds, and also 
neutralize the toxicity of some herbs (Zhang and Wumanjiang, 2003). 
The in vitro studies used in this project served as screening systems of potential 
anti-diabetic traditional Chinese herbs. But the incubation time of herbal extract in each 
assay was short (several seconds to 3 hours), it could not show the effect of chronic 
treatment of the herbs. 
The three herbs which showed the most potent effect in vitro did not show any anti-
diabetic effect in vivo. The contradicted results might be due to the chronic effect of 
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T C M . As mentioned before, T C M usually emphasizes on improving the interior yin and 
yciy^ g balance, it might not exert a spontaneous action on lowering of blood glucose level 
immediately after administration as fast as that of western medicine; on the contrary it 
might slowly improve the glucose homeostasis by acting on related target cells such as 
pancreatic P-cells, liver and adipocytes etc., and this might need weeks to months to 
show the effect. For improvement, long-term herbal extract administration could be 
done in any animal model, and the chronic effect of the extracts could be studied. 
The use of T C M is commonly done by first boiling the herb with water, and then 
followed by drinking the extract. Most of the studies in this project used herbal water 
extracts, but not for the B B M V assays. In the B B M V assay, herbal organic (hexane and 
dichloromethane) extracts were used, and we found that the extracts also give effective 
anti-diabetic effects. It reveals that some active components are water soluble, but some 
are also water insoluble. The use of organic extract allows those water insoluble 
components to be studied. 
6.5 Future Directions 
After purification of other active components from Cortex Moutan (2,5-dihydroxy-
4-methylacetophenone, 2,5-dihydroxy-4-methyoxyacetophenone and 3-hydroxy-4-
methoxyacetophenone), further studies are needed to find out the structure-activity 
relationship between each acetophenone (including paeonol and acetovanillone) as we 
could see from the in vitro results that different functional groups on different positions 
of acetophenones could affect their activities. To achieve the purpose, other similar 
structure compounds could be purchased or modify the structures by chemists, and the 
anti-diabetic mechanism of these compounds could be studied in animal model. This 
experiment could investigate the anti-diabetic activities inside animal, and the final aim 
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is to bring the effective compound(s) to clinical trial. 
Paeonol showed positive results in both in vitro and in vivo assays, and it has 
potential to be leading compound anti-diabetic drug development. The disadvantages of 
developing paeonol are: 1) Paeonol showed low acute toxicity after i.v. injection, i.p. 
injection and orally feed of dosage 196mg/ml, 78Img/ml and 3430mg/ml respectively 
into mice, the toxicity observed were inhibitory effect in central nervous system, 
decreasing in body temperature etc.; 2) The blood glucose lowering effect of paeonol 
was only about 50% compared with that of metformin (a commonly used western oral 
medication), and it did not give a strong reason to support its development. However, 
there are some advantages of the developing paeonol: 1) Metformin has many side-
effects, such as diarrhoea, nausea, lactic acidosis etc., paeonol, which is purified from 
commonly used nature plant and widely used by Chinese people, is more safe to use and 
proved to have less side-effects under normal human dosage according to 
pharmacopoeia; 2) The action of metformin is to inhibit the gluconeogenesis and also 
improve the insulin sensitivity in peripheral tissues, while paeonol exerts its effect on 
more up-stream mechanism by inhibiting glucose uptake from intestine, acts as the first 
barrier to lowering glucose content inside the patient's body. Hence, it can be used as a 
leading compound of further drug investigation by lowering its toxicity and increasing 
activity by modifying its structure 
The future investigation on the anti-diabetic effect of paeonol can be focusing on 
synergistic effect of metformin and paeonol. As metformin is usually administrated 
together with sulfonylureas, which reduce the blood glucose level after meal by two 
different mechanisms, hence it can be a possible aspect to study their synergistic effect, 
and the supplementary effect of paeonol on western drugs available nowadays. 
Purification of active components from Radix Ophiopogonis is also possible. 
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Although it did not significantly improve oral glucose tolerance, it gave a high degree of 
intestinal glucose absorption suppression in both hexane and dichloromethane fractions. 
The negative result in O G T T might be due to a high glucose content in this herb (the 
water extract of Radix Ophiopogonis is sweet in taste and very sticky in texture, and it 
was suspected to have high glucose content). To confirm this hypothesis, the glucose 
content of this herb should be investigated first. 
Other mode of action in regulating blood glucose level could be investigated, such 
as protection and restoration of pancreatic P-cell function (Cabrera-Valladares et al., 
1999) and glucose uptake in skeletal muscle (Logie et al., 2005). In type 2 diabetes, 
patients have limited insulin secretion and insulin resistance (World Health 
Organization, 1999). Further study is needed on the enhancing effect of insulin secretion 
and improvement of insulin sensitivity. 
The in vivo synergistic effect on Cortex Moutan, Rhizoma Smilacis Chinensis and 
Rhizoma Alismatis was studied in this project, but negative results were obtained. This 
study was done by mixing three herbal water extracts of the same amount and 
administrated to STZ-rats, so the in vivo result was from the effect of individual herb. 
Further studies could be done by extracting three herbs together with water, and there 
might be a chance to form new compounds with effective anti-diabetic effects. 
Some other genetically diabetes animal models can be used instead of STZ diabetic 
rat model in terms of investigating anti-diabetic effect of herbs (Liang et al., 2005): 
1. Genetic diabetic mice (C57BL/KsJ-m+/+Lepr) [by ？m+/+db crossing (?m+/+db] 
+db/+db : black, obese, m+/+db : black, lean, m+/fn+ : grey, lean: 
/o 
Female +db/+db mice and their female lean littermates (C57BL/KsJ-Le/> ) with 6-
8 weeks of age will be used. They are housed 10 mice per cage and given access to 
water and food ad libitum. 
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The +db/+db mice and age-matched heterozygous lean littermates (control group) 
will be each randomly divided into different treatment groups. Herbal treatments 
with dosage equivalent to human dosage were administered via oral gavage once 
per day for 30 days. Body weights of the mice will be measured on the first and 
every 7 days of dosing. On day 31, O G T T are performed after fasting the mice 
overnight (18 hours), a drop of whole blood samples will be collected from tails 
onto sample window of blood glucose electrode (Precision Q.I.D., MediSense, 
Abbott). The blood glucose level will be measured by blood glucose sensor 
(Precision Q.I.D., MediSense, Abbott) by inserting the electrode into the sensor. 
Blood glucose level of diabetic control mice is steady and the level is around 
16mmol/L. 
2. Fertile Zucker diabetic fatty (ZDF) rats 
Female ZDF rats at 6 weeks of age (ZDF/Gmi-fa) are housed four rats per cage and 
given access to water and food ad libitum. To develop hyperglycaemia, these rats 
were fed with a diabetogenic diet for 3 weeks. After 3 weeks on the diabetogenic 
diet, only the hyperglycaemic rats (blood glucose > 300mg/dl) were selected for the 
studies, and these ZDF rats were maintained on the diabetogenic diet through the 
entire study period. 
The rats are each randomly divided into different treatment groups. Herbal 
treatments with dosage equivalent to human dosage were administered via oral 
gavage once per day for 1 day (acute treatment) and for 30 days (chronic treatment). 
Body weights of the rats will be measured on the first and every 7 days of dosing. 
On day 31, O G T T are performed after fasting the rats overnight (18 hours), blood 
samples will be collected from tails at 15, 30, 45, 60 and 90 minutes in heparinized 
tubes after glucose challenge. Blood plasma will be collected by centrifuging the 
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whole blood sample at 4000 rpm for 5 minutes. The plasma glucose level will be 
measured by glucose assay kit. 
Finally, a new formula of treating diabetes can be made by the six chosen herbs 
as they all exerted their anti-diabetic effect on different mechanisms according to the 
in vitro results (Table 6.2). They are all commonly used herbs in traditional herbal 
formulae, and it is reasonable to make them into one formula after consulting to an 
herbalist. This formula can be brought to in vitro assays and also in vivo assay again 
to investigate the synergistic effect, or by several trials, the number of herbs can be 
narrowed down according to the results. 
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Herb Name H4IIE hs68 3T3-L1  
(CH2CI2) (Hexane)    
^ , ^ , -7，oZo I -80.00% +78.90% (-insuhn) 
Cortex Moutan (5) / ** (0.01) (0 0、） 
* * 
^ “ ~ ^ ； -8.20% + = % + 8 2 . 8 0 % ( - i n s _ Rhizoma Alismatis (5) / ** (O.l) 
sjsi；氺 、士 
Rhizoma Smilacia ^ ； ^ ^ 8 7 , 7 0 % (-insulin) 
Chinensis * * * 
Cortex Phe l lodendr i -8155% _23.50% -69.48% +5,。.，+33.32% ( + m s _ (10) 
(£) * *** +63.44 %(-insulin) (1) 
Rhizoma Copitidis -28.63% -58.13% +58.19% -35.28% (^insulin)� * 
(丄） ** *** (0.01) +79.03% (-insulin) (0.1) * * 
Radix Ophiopogonis；;；;^~-93.10% -98.l3o/o +50.450/0111:/二i广 
(0 9\ *** *** (on (u.叫 
…」） （u.U -3.81% (-insulin) (0.1) 
Table 6.2 Overall summary of in vitro studies of six chosen traditional Chinese 
herbs. The number blanketed represents the concentration in mg/ml aqueous extract, 
except in B B M V studies with hexane or dichloromethane extracts. Significantly 
different from control: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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6.6 Conclusions 
A study platform with various in vitro models was established for the screening of 
potential anti-diabetic agents with different modes of actions. 
Although in vitro studies suggested potential anti-diabetic effects of Rhizoma 
Copitidis, Cortex Phellodendri and Radix Ophiopogonis, the effects were not shown in 
animal studies. Cortex Moutan, Rhizoma Smilacis Chinensis and Rhizoma Alismatis 
water extracts did not possess in vivo synergistic anti-diabetic effects. 
Cortex Moutan hexane and dichloromethane fractions potently inhibited intestinal 
glucose absorption in vitro, and paeonol was responsible for part of the activity in both 
fractions, while other minor acetophenones were responsible for another part of the 
activities。The anti-hyperglycaemic effect of paeonol was further confirmed in this 
report。The structure-activity relationship of all purified components needed to be 
further studied. Their pharmacological and phytochemical properties, as well as the 
potential of being new anti-diabetic agents should be further explored. 
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